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ABSTRACT
TREATMENT OF AORTIC HEART VALVE CONDUIT WITH GLUTAMINE AND
HEAT SHOCK AS A MEANS TO DETER THE CONSTITUENT CELLULAR
POPULATION FROM BECOMING APOPTOTIC
Alyce Marie Linthurst Jones
Old Dominion University, 2012
Director: Dr. Lloyd Wolfinbarger, Jr.

Cryopreserved allograft heart valves represent the best solution for a
patient with a failing heart valve. However, the constituent cells become apoptotic
and within months of transplant the heart valve becomes acellular and the
recipient's cells do not repopulate the allograft (3, 51). A strategy to prevent this
situation would be to minimize or prevent apoptosis from occurring by
strategically altering steps during heart valve processing. Recently it has been
demonstrated that: 1) Heat shock protein 70 is a negative modulator of the
apoptotic cascade; 2) Cells in culture exposed to hypothermic conditions produce
heat shock protein 70 upon rewarming; and 3) Glutamine can induce heat shock
protein 70 production. The purpose of the current research is to apply these
concepts to allograft heart valve tissues and begin to understand the mode(s) of
action by investigating the resultant intracellular heat shock protein 70
concentration, presence of caspase 3, presence of cytochrome c outside of the
mitochondria and compromised DNA.
Allograft heart valve conduit tissue was processed traditionally at 4°C and
37°C

with

and

without glutamine

and assessed

prior

to

and

after

cyropreservation. Intracellular heat shock protein 70 and cytochrome c
concentration inside and outside of the mitochondria was assessed utilizing
enzyme-linked immunoassay; the presence of caspase 3 was assessed utilizing
immunohistochemistry and histomorphometry; and the presence of compromised
DNA was assessed utilizing the TUNEL assay and histomorphometry. It was
found that treatment of allograft heart valve conduit tissue at 37°C plus glutamine

lead to a statistically significant increase in heat shock protein 70 concentration,
maintenance of the mitochondrial cytochrome c concentration, less caspase 3
positive cells and less TUNEL positive cells relative to the other three treatment
groups immediately prior to cyropreservation and after thawing and subsequent
incubation at 37°C for seventy-two hours.
Therefore it is concluded that allograft heart valves can be processed at,
37°C with glutamine, which will facilitate increased amounts of heat shock protein
70 thereby reducing the amount of apoptotic cells. The presence of heat shock
protein 70 appears to modulate apoptosis at or upstream of cytochrome c
release from the mitochondria.
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CHAPTER 1
INTRODUCTION

Each year, approximately 2600 allograft heart valves are transplanted into
adults and children with congenitally malformed or degenerating native or
bioprosthetic valves (1). Allografts are human tissues, which are procured from a
deceased donor who has previously consented for their organs and tissues to be
removed with the intent of them being transplanted into another human being.
Surviving family members may also consent to organ and/or tissue donation.
Cryopreserved allograft heart valves are the best replacement for failing heart
valves for three reasons: 1) allograft heart valves provide the best hemodynamic
support due to their geometry; 2) allograft heart valves are the least
thrombogeneic option available; and 3) allograft heart valves best resist
calcification relative to bioprosthetic (porcine or bovine) valves. However,
cryopreserved allograft valves have inherent problems that prevent them from
being the perfect replacement heart valve. These problems include the inability to
support cellular in-growth or remodel once implanted in vivo, and the propensity
to calcify, which is often accentuated in pediatric recipients. All of these
weaknesses can potentially be attributed to cryopreserved valves becoming
acellular within months of transplant (2, 3, 4, and 5). The rapid in vivo
decellularization of the allograft heart valve is attributed to the cells being
apoptotic, having undergone programmed cell death, either at the time of
transplant or shortly thereafter. Without a viable cell population, the valves
cannot renew their collagen and elastin matrix which would allow them to grow
with a pediatric recipient and resist normal wear and tear over a lifetime in vivo.
Additionally, the presence of apoptotic cells provides the necessary reactants
(calcium and phosphate) to initiate calcification. Conversely, the presence of a
viable cell population would allow for both the continuous renewal of the
extracellular matrix, thus resisting degradation, and production of factors to aid in
The journal model for this Dissertation is The Journal of Biological Chemistry.
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combating calcium formation in the arterial wall (6). Therefore, there is a need to
develop a mechanism to reduce the propensity of the constitutive cells in allograft
heart valves to become apoptotic, which should improve the long-term durability
of allograft heart valves. To successfully do this requires improved understanding
of the cellular events occurring between procurement and cryopreservation and
the ability to manipulate these events to halt the constitutive cells in the allograft
valves from progressing to apoptosis. It has been reported in the literature that
heat shock protein 70 (Hsp70) is capable of halting the progression of apoptotic
cascade and is inducible via glutamine (7). Therefore a potential strategy to
prevent the constitutive cells in an allograft heart valve from becoming apoptotic
might be to engage the heat shock response and Hsp70 expression through the
use of heat and/or by supplementing the disinfection media with additional
glutamine during processing.
To date, researchers have not attempted to manipulate the heat shock
response (any of the heat shock protein family members) during the processing
phase for allograft heart valves destined for cryopreservation. Successful
application of this strategy might be utilized to improve allograft heart valve
processing methods, thus resulting in the maintenance and long term viability of
the primary constitutive cell population, vascular smooth muscles cells, in heart
valves once transplanted.

1.1 PURPOSE AND HYPOTHESES

It has been demonstrated that cells exposed to hypothermic temperatures
and subsequently returned to physiological temperature can be stimulated to
produce the anti-apoptotic protein, Hsp70, when returned to physiological
temperature, 37°C (8). A second strategy to chemically stimulate Hsp70,
reported in the literature, is addition of glutamine beyond what is present in
traditional tissue culture media (7, 9). These results suggest the possibility that
the cryopreserved allograft heart valve cell population can be preconditioned
during processing (Chapter 2.1) to minimize the potentially pro-apoptotic effects
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of hypothermic insult that occurs during transport and processing. As a result of
preconditioning (hypothermia followed by return to physiological temperature in
the presence of supplemental glutamine), when the valve is thawed and
transplanted, it may have a reserve of protective heat shock proteins to aid in
correctly refolding proteins that may be denatured during the cryopreservation
process. Another potential scenario is that the allograft heart valve cell population
may be preconditioned to efficiently produce these heat shock proteins upon
rewarming the graft prior to implantation, consequently minimizing the prevalence
of apoptotic cells and thus preventing the valve from becoming acellular in vitro.
Based upon these observations from the literature, the following hypotheses
were proposed: 1) Returning the heart valve to physiological temperature during
processing will result in an increase in Hsp70 in the constitutive cells, thereby
minimizing the presence of pro-apoptotic proteins and apoptotic cells; 2)
Returning the heart valve to physiological temperature in the presence of
glutamine during processing will result in an increase in Hsp70 in the constitutive
cells, thereby minimizing the presence of pro-apoptotic proteins and apoptotic
cells; and 3) Upon thawing the allograft heart valve post-cryopreservation and
incubating it under physiological conditions, increased amounts of Hsp70 in the
constitutive cells will minimize the presence of pro-apoptotic proteins and
apoptotic cells in conduit tissue. Information gained from exploring these
hypotheses may provide important information needed to improve the cell
viability, and hence long term durability and utility, of implanted cryopreserved
allograft heart valves. The end result of exploring and beginning to understand
the cellular events that occur during allograft heart valve processing could have a
positive impact on the thousands of adults and children who receive these life
saving allograft heart valves every year.
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CHAPTER 2
BACKGROUND OF THE STUDY

2.1 STANDARD ALLOGRAFT HEART VALVE PROCESSING

A discussion of the potential cellular mechanisms involved in
cryopreserved allograft heart valves becoming acellular in situ, requires
understanding how an allograft heart valve is processed and what is meant by
the term "processed." Once an individual dies and consent is given for organ
and/or tissue donation, the heart is aseptically removed from the donor, within
24-hours of asystole and washed repeatedly with cold (1-10°C) sterile isotonic
solution to remove all of the blood. The heart is then transported to a tissue bank
within 24-hours of procurement on wet ice (1°C - 10°C) in sterile isotonic solution.
Once at the tissue bank, the aortic and pulmonary valves are dissected free from
the heart in cold (1-10°C) sterile isotonic solution and placed into a cocktail of
antibiotics and tissue culture media for 24 +/- 2 hours at 1-10°C. The final step is
to cryopreserve the valves in a solution comprised of 10% dimethylsulfoxide
(DMSO), 10% fetal calf serum and RPM11640 tissue culture media. The
cryopreservation process is performed using a control rate freezer that facilitates
cooling the tissue at 1°C per minute to control ice crystal formation. One the
tissue reaches -40°C it is transferred to the vapor phase of liquid nitrogen (-120
to -195°C) for storage until shipment in liquid nitrogen vapor for transplantation.
Obviously, the valves spend a considerable time during processing at
hypothermic conditions.

2.2 HEAT SHOCK PROTEIN 70

Ferruccio Ritossa first described the heat shock phenomenon in 1962
after a laboratory worker accidently increased the temperature in the Drosophila
incubator (10). When the fly's salivary glands were microscopically examined, it
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was noted that the polytene chromosomes had a puffed band (10). This indicated
that the gene represented by that band was experiencing elevated rates of
transcriptional activity. In 1974, Tissieres etal. first reported the presence of
unique proteins in Drosophila melanogaster ex posed to elevated temperatures
(11). These proteins were aptly named heat shock proteins due to their mode of
expression. Since then, a multitude of heat shock proteins have been discovered
in all organisms from bacteria to humans and characterized into families
according to their relative molecular weights, cellular compartment and
distribution (82,123). The Heat Shock Protein 70 Family can be found in the
cytosol, nucleus, mitochondria and the endoplasmic reticulum (82). Heat shock
proteins have also been demonstrated to be highly conserved; more specifically,
the Hsp70 family demonstrates 60-80% sequence homology among eukaryotes
(12).

One of the most interesting and unique properties of heat shock proteins
is they are an integral part of normal cell physiology and they are an integral part
of cell/organism survival during periods of extreme physiological stress (45, 63,
124,122). During protein translation, when the organism is euthermic (~37°C),
Hsp70 ensures nascent peptide chains with exposed hydrophobic residues do
not inappropriately aggregate with one another rendering them inactive. Hsp70
also functions as an intracellular protein chaperone to transport peptides to
desired locations (86, 87, 88, 89, 90). However, during periods of extreme
physiological stress, such as changes in pH, cell oxidative state, nitrogen
reactive species, superoxide, hypoxia, ischemia, inflammation and accumulation
of malfolded or denatured proteins, Hsp70 has been demonstrated to be
essential and integral to cell and organism survival (85, 91, 102, 103, 127). The
Hsp70 binding event may prevent further unfolding of the target protein, may
refold the protein or may continue to fold the protein into a functional
configuration within a stressed cell (12). Another function of Hsp70 is it may
shuttle malformed proteins to the ubiquitin and proteolysis degradation pathways
as the accumulation of misfolded proteins is a stimulus for apoptosis a
subsequent cell death (12, 111)
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A brief understanding of the Hsp70 gene, its inducible transcription and
translation and protein structure will facilitate putting the results of the research
described herein into perspective. The Hsp70 gene, as found in the genomic
DNA, is comprised of 2,440 base pairs with a 212-base pair leader sequence and
242-base pair 3' untranslated region (14,110). The 5' region contains at least
two regulatory elements that interact with heat shock transcription factors (HSFs)
(99, 100,110). The efficiency of the Hsp70 transcriptional process is attributed to
the constitutive presence of inducible HSFs monomers, the lack of introns in the
Hsp70 gene, the presence of an internal ribosome entry site in the 5'
untranslated region of the Hsp70 mRNA, alternative Hsp70 mRNA splicing and
heat-induced stabilization of Hsp70 mRNAs (15,16, 17, 74, 110, 128).
During periods of stress, HSFs separate from Hsp70 in the cytosol, are
phosphorylated by protein kinase, oligomerize as homotrimers in the cytosol,
enter the nucleus and bind to heat shock elements (HSE) in the hsp70 gene
promoter and cause transcription to be initiated (Figure 1) (92). The increase in
hsp70 is attributable to the activation of heat shock transcription factor 1 (HSF1).
Interestingly, HSF1 is hyperphosphorylated when activated by heat treatment of
cells. In contrast, HSF1 activated by cold shock (2-3°C) followed by rewarming to
room temperature (22°C), is not hyperphosphorylated and this difference may
point to a different mechanism for mediating the response to cold and heat
induced cellular stress responses (18). This lack of phosphorylation may affect
how tightly HSF1 binds to its target DNA and what target genes it comes into
contact with and thereby activate or down regulate these genes. During induction
of the heat shock response, the resultant protein products can account for 15%
to 25% of the total intracellular proteins within minutes after physiological stress
(19).
From a structural perspective, heat shock proteins are ATP binding
proteins and consist of three major functional domains. Figure 2 (page 8) is a
ribbon crystal structure of the three Hsp70 functional regions. The N-terminal
ATPase domain is 44kDa, binds adenosine triphosphate (ATP), hydrolyzes it to
adenosine diphosphate (ADP) and is characterized by having four domains that
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FIGURE 1. Hsp70 Inductive Signals, Hsp70 Gene Activation and Hsp70
Synthesis. A myriad of extracellular stimuli can result in activation of the heat
shock response. Inducible Hsp70 transcription factors (HSFs) are bound to
Hsp70 in the cytosol and maintained in an inactive state. However, upon
application of an external stressor the HSFs separate from Hsp70 are
phosphorylated (P) by protein kinases and form trimer complexes in the cytosol.
The complexes proceed to the nucleus, enter and bind to heat shock elements
(HSE) in the promoter region of the Hsp70 gene. Transcription of Hsp70 mRNA
commences and exits the nucleus and enters the cytosol, where new Hsp70 is
synthesized (21).
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N-Terminal Domain
C-Terminal Domain

Substrate Binding Domain with
Substrate
FIGURE 2. Crystal Structure of Hsp70 with Bound Substrate. The 44kDa Nterminal region contains the ATPase domain, the 18 kDa substrate binding
domain and the 10kDa C-terminal region that closes in the presence of tightly
bound protein (23).

form two lobes with a cleft between them (20). The hydrolysis of ATP to ADP
fuels the conformational changes for the remaining two domains. The substrate
binding domain is 18 kDa and interacts with hydrophobic regions on target
peptide and proteins, but favors peptides with basic residues over those with
acidic residues. It is characterized by having four anti-parallel beta pleated
sheets and one alpha helix (22). The C-terminal domain is 10 kDa and aids in
regulating how tightly a target protein is bound in the substrate binding domain. It
is characterized by an alpha helix followed by a glycine-proline rich aperiodic
segment next to a highly conserved segment containing glutamic acid, valine and

g

aspartic acid (23). This conserved sequence affects the amount of mRNA
translated during heat shock (25).
The strength of the target peptide binding is directly related to whether
Hsp70 is bound to ATP (loose target peptide interactions) or ADP (tight target
peptide interactions). The hydrolysis of the phosphate group from the ATP
molecule results in Hsp70 undergoing an allosteric change that sequesters the
bound peptide. The strength of binding is dictated by the target peptide
constitutive residues and is a likely control point for Hsp70 activity. Peptides
containing large hydrophobic residues and aromatic residues stimulate the
ATPase activity of Hsp70; conversely, peptides containing hydrophobic and basic
residues are poor ATPase stimulators. The amino acid composition of the target
peptide chain is used to distinguish native versus unfolded proteins. Native
proteins merely need to be chaperoned to their destination, whereas Hsp70
prevents aggregation of newly forming nascent peptide chains and production of
misfolded proteins that could initiate apoptosis (26). Once the protein is
completely translated, a nucleotide exchange factor causes ADP to be released
from Hsp70 and a new ATP to bind to Hsp70 which results in Hsp70 undergoing
a conformational change and the new properly folded protein is released.
In summary, Hsp70 is ubiquitously expressed across phyla and cellular
compartments. It is constitutively expressed to prevent aggregation of newly
formed nascent peptides and refold improperly folded proteins. Upon application
of physiological stress to the cell, Hsp70 transcription is significantly upregulated
and highly efficient. During these periods of stress, Hsp70 contributes to rescuing
the cells through refolding denatured proteins, at a minimum. Therefore, it is
reasonable to suggest that Hsp70 is a key element in the maintenance of
intracellular and organism homeostasis.

2.3 HYPOTHERMIA AND THE HEAT SHOCK RESPONSE

Hypothermia is often used as a tool to arrest metabolic activity within cells,
thereby minimizing autolysis, free radical formation, reactive oxygen species
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formation and other postmortem changes that are not compatible with cellular
viability (13). Several roles for hypothermia to protect cells from becoming
apoptotic or necrotic have been reported in the literature (27, 28, 116,119).
Some examples are performing cardiac bypass and spinal surgery under mild
hypothermia, approximately 33°C, treating stroke patients with hypothermia and
the well documented use of hypothermia to preserve whole organs for transplant.
However, prolonged exposure to hypothermia has its own inherent risks such as
lipid peroxidation, lipid membrane phase transition and lipid membrane
leakiness. Compromising the integrity of cell and organelle membranes can
potentially result in apoptosis or necrosis (29). In vitro experimentation with
mammalian cells exposed to hypothermia have demonstrated increased
populations of misfolded proteins that could result from denaturation during
hypothermic insult or from nascent proteins that did not complete the folding
process (30).
Hypothermia has also been utilized in nature as a successful survival
strategy. Hibernating animals undergo a process called hypothermic
preconditioning where they cycle between euthermic and various degrees of
hypothermia to survive during winter by maximizing their food stores when
sources are scant. They do this by reducing their body temperature to 15°C for 7
days and then rewarming to 37°C for several days. This is followed by 20 days at
approximately 5°C (31). This strategy is hypothesized to increase the efficiency
of Hsp70 induction and production during each subsequent hibernation cycle to
protect animals from the detrimental cellular effects of prolonged exposure to
hypothermic conditions and aid in their recovery. This model from nature points
to a mild hypothermic preconditioning followed by rewarming to 37°C followed by
a deep hypothermic episode from which the animal successfully recovers. This
finding may provide a parallel to one of the key experimental groups investigated
during the research described herein.
Other researchers have utilized cell culture systems as well as small
animal models to better understand how the Hsp70 response can be
manipulated using hypothermia to benefit cell survival for potential human clinical
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applications. Research by Currie et al demonstrated that hearts subjected to cold
ischemia for 17 hours at 4°C exhibited significant Hsp70 production upon
reperfusion at 37°C (32). This same experiment carried out with mammalian cells
in culture demonstrated that when incubated at 4°C and subsequently rewarmed
to 37°C the cells had high levels of Hsp70 (33). Importantly, Laios et al
conducted research to investigate the chronology of Hsp70 induction post
hypothermic exposure upon return to 37°C. An in vitro model of cardiac myocytes
demonstrated that after one hour of hypothermia at 4°C, Hsp70 production
peaked after 4-6 hours of rewarming at 37°C (27).
Liu etal, investigated incubating human IMR-90 diploid fibroblasts at4°C
for 0, 1,1.5, 2, 2.5, 3, 3.5 or 4 hours followed by incubation at 37°C for 5 hours to
assess for differential production of Hsp70 protein (33). Pulse labeling of the cells
with 35S-labeled amino acids during the last hour of incubation at 37°C
demonstrated that the longer the cells were held at 4°C, the more Hsp70 was
produced by the cells upon return to 37°C. In particular, the cells incubated at
4°C for 4 hours prior to their incubation at 37°C produced similar amounts of Hsp
70 to the control cells that were traditionally heat shocked by placing them at
42°C for 5 hours.
Another finding of the Liu study was that those cells that were cold
stressed for the longest period of time, produced Hsp70 for the longest period of
time (greater than 8 hours) upon rewarming, relative to the other experimental
groups (33). To further investigate their findings, an electromobility gel shift assay
(EMSA) was performed. The purpose of the EMSA was to demonstrate if the
HSF binding to the heat shock element (HSE) in the hsp70 gene in the cells that
were rewarmed was equivalent to HSF binding to the HSE in the positive control
cells (traditionally heat shocked at 42°C). Their results demonstrated that an
increase in the amount of HSF binding to the HSE was proportional to the length
of time the cells were held at 4°C. Those cells with the longest incubations at 4°C
had EMSA results equivalent to the positive control cells that were traditionally
heat shocked. Liu et al. interpreted the data to mean that there was an increase
in the transcriptional activity associated with the hsp70 gene. Their conclusion
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was that the magnitude and the duration of Hsp70 production were directly
related to the severity of the cold stress. In addition, cells that were maintained at
4°C without rewarming had no change in the amount of Hsp70 present in the
cells or heat shock element (HSE) binding.
Fujita et al subjected cardiomyocytes to hypothermic treatment and found
that Hsp70 expression increased as the cells were returned to physiological
temperature, rather than as they were being cooled. They also determined the
amount of Hsp70 produced was proportional to the duration of hypothermia. After
rewarming, the cardiomyocytes retained their functionality as assessed by
electromechanical activity (43).
In support of the data reported by Fujita et al, Cullen et al exposed one
group of rats to 2-3°C for 8 hours and a second group of rats to 2-3°C for 8 hours
plus an additional incubation at room temperature (22°C) for one hour. At the
conclusion of their respective incubations the animals were sacrificed and the
hearts, kidneys, livers and lungs were removed and analyzed for hsp70 mRNA
production. It was determined that hsp70 mRNA was present in all the organs
from the hypothermic treatment group (group one) but at very low amounts.
However, the same organs from the animals that underwent hypothermic
treatment followed by rewarming to 22°C (second group) had at least doubled
the amount of hsp70 mRNA in their hearts and kidneys and increased it by six
fold in the liver (18).
Thus the research conducted to date on Hsp70 indicates: 1) Hsp70 can be
induced in response to a wide variety of physiological insults such as
hypothermia and denatured intracellular proteins, not just heat, 2) Hsp70 can be
induced to be transcribed and translated in response to changing the
environment from 4°C to 37°C and 3) the amount of Hsp70 formed is directly
related to the time at hypothermic temperatures and impacts the chronology of
Hsp70 formation. It is intriguing to consider the possibility that cells incubated at
4°C would perceive returning to physiological temperature, 37°C, as heat shock.
Therefore the hypothesized impact of transferring allograft heart valves from
1-10°C to 37°C for a prescribed period of time is that the constitutive cell
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population will have an increased amount of Hsp70 present at the conclusion of
the disinfection incubation and be pre-conditioned for the second hypothermic
insult that occurs during cryopreservation. The benefit of heat shocking the cells
to produce Hsp70 during antibiotic disinfection may be to promote the refolding of
proteins which were denatured and/or misfolded during hypothermic transport.
This "proteotoxicity," is a potent stimulator of the intrinsic apoptotic cascade (35).
The initial heat shock may also precondition the cells and aid in their recovery
after cryopreservation. Therefore, reducing the proteotoxicty of the constitutive
allograft heart valve cells through augmenting the amount of Hsp70 present
would be expected to prevent the apoptotic cascade from proceeding from this
type of pro-apoptotic signal.

2.4 GLUTAMINE AND HEAT SHOCK PROTEIN INDUCTION

L(+)-Glutamine (Gin) is the most abundant amino acid in plasma and
many tissues (7). Gin is a neutral amino acid with a molecular weight of 147 Da.
It can enter the cell through sodium-dependent systems and sodium independent
systems (36). Gin is not considered an essential amino acid; however, when the
body is under physiological stress, it may be essential for survival (120). Recently
published data on a meta-analysis of all human clinical trials using Gin as the
sole agent in surgical and critical illness demonstrated a strong trend toward
reduction of infection complications post-surgically and a reduction in
complications and mortality rates in the critically ill (37). Interestingly, Gin is
known to stimulate the production of Hsp70 in the gut and retina when under
physiological stress (7). This stimulation is advantageous because, as discussed
in the previous chapter, Hsp70 protects cells under stress by binding to the
hydrophobic sites on intracellular proteins that may have become denatured
during the physiological stress.
There are several precedents for adding Gin to cells or tissue to induce
Hsp70 production. Gin has been shown to enhance the synthesis of Hsp70 in
Drosophila cells and Chinese hamster ovary cells (13, 106). Additionally, it has
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been demonstrated that other neutral, small amino acids such as glycine and
alanine protect renal tubule cells from lethal stress and injury caused by
ischemia, hypoxia, anoxia and toxic chemicals (39, 108). These amino acids
were also cytoprotective for hepatocytes exposed to cold storage conditions (40).
Kojima et al. tested the efficacy of administering various Gin dosages to rats. The
rats were anesthetized 1, 2, 4 or 6 hours after Gin administration and their hearts
were harvested, stored at 4°C in University of Wisconsin solution for 24 hours,
heterotopically transplanted to the neck of syngeneic recipient rats and monitored
daily for function by palpation. Several hearts were not transplanted but
sacrificed for immunoblotting for the presence of Hsp70. The immunoblotting
demonstrated Hsp70 at 1 hour and maximally 2 to 4 hours post Gin
administration (9). The results of the study demonstrated that the more Hsp70
detected in the surrogate tissue, the longer the heterotopically transplanted heart
beat in the rat. This research dealt specifically with the transplant of the entire
heart and a hypothermic incubation for 24 hours prior to transplant. In contrast,
the current research deals with the excision of the aortic valve, hypothermic
incubation for 24 to 48 hours and heat shock followed by cryopreservation.
The research described thus far has focused on inducing Hsp70 through
addition of Gin to the culture medium or administering it to a test animal.
Research conducted in Wischmeyer's lab has begun to elucidate the
mechanisms involved (38). The experimentation was performed by heat shocking
mouse embryonic fibroblasts in a water bath at 44°C for 50 min after
administration of 0-16 mM Gin (8 mM was optimal). From this set of experiments
they concluded (Figure 1 is a helpful reference to follow their conclusions): 1) Gin
increased binding of HSF-1 to the HSE, and 2) Gin enhanced phosphorylation of
nuclear HSF-1 which is the final step in the HSF-1 transactivation pathway
leading to transcription of Hsp70. Another group (Ropeleski et al) examined the
mechanism by which Hsp70 transcription is potentiated by Gin using a similar
model system as Wischmeyer. They concluded that: 1) Gin is able to augment
the amount of Hsp70 transcript produced, 2) Gin is able to increase HSF-1 DNA
binding during heat shock and, 3) no Gin dependent differences in HSF-1
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phosphorylation, trimerization, nuclear localization, or HSF-1 promoter activity
were demonstrated as a result of administration of Gin. They hypothesize that
Gin is able to: 1) interact with HSF-1 and the core transcriptional machinery, 2)
affect the chromatin organization of the 5' flanking regions of the Hsp70 gene,
and 3) affect other trans-factors upstream in the Hsp70 promoter. In spite of this
progress, the actual mechanism of how Gin positively affects transcription and/or
translation of Hsp70 remains to be conclusively demonstrated (41,112).
Based upon the Gin research discussed above, it seems plausible that
Gin will successfully induce Hsp70 in aortic conduit cells subjected to the
aforementioned regime. Therefore, pre-conditioning the constitutive cells to
produce Hsp70 may protect the viability of the constitutive smooth muscle cell
population and thus positively impact the durability of the valve so it functions for
a clinically significantly longer period of time in situ.

2.5 APOPTOSIS

Research performed during the last twenty years has transformed
apoptosis from a field defined by morphological changes and genetic demise to a
well characterized deconstruction of the cellular machinery that has many modes
of regulation. As a result, the literature review in this and subsequent chapters
will be limited to apoptosis and the associated factors as they relate to the
research to be reported herein. The term apoptosis appeared in the peerreviewed literature in 1972 to describe a structurally distinct mode of cell death
within living tissues (42). The hallmark changes an apoptotic cell undergoes are
chromatin condensation, DNA laddering, cell shrinkage, phosphatidylserine
exposure on the exterior of the phospholipid bilayer and membrane blebbing.
Apoptosis is a catabolic process, requiring ATP, which ensures that the regulated
cascade of events proceeds in an orderly fashion so as not to elicit an
inflammatory response. An alternative pathway for cell death is necrosis, a nonordered process by which the contents of damaged cells are released inside the
organism and result in an inflammatory response.
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Apoptosis is a necessary part of normal cell function. It is involved in
embryological development, normal tissue turnover, atrophy, negative selection
of T-cells in the thymus and T-cell mediated killing. Apoptosis is also a necessary
and important part of organism survival after exposure to cytotoxic compounds,
hypoxia or viral infection. As a result, the organism's affected cells are efficiently
removed and new healthy cells can replace them so that the organism might
survive the physiological insult. To underscore the importance of apoptosis, cells
that lose their ability to undergo apoptosis are transformed into neoplastic cells.
Apoptosis can proceed by two main pathways: the mitochondrial (intrinsic)
pathway and the death receptor (extrinsic) pathway. The mitochondria serves
multiple functions during the progression of the intrinsic pathway: 1) as an
integrator of the multiple signals traveling along the proapoptotic cascade, 2) as a
coordinator of the catabolic reactions leading to apoptosis and 3) as a gate
keeper of proapoptotic proteins (BAX). Therefore upon permeabilization of the
outer mitochondrial membrane and disregulation of Bcl-2 and Bcl-2 related antiapoptotic proteins, cytochrome c is released from the intermembrane space, and
the caspase cascade is activated (42). Figure 3 on page 18 is a schematic
representation of the intrinsic apoptotic pathway. The extrinsic apoptotic pathway
is activated by cross-linking specific receptors on the surface of the cell. These
receptors are often referred to as death receptors and include TNFR1,
CD95/APO-1, Fas and TRAIL-R1. The structural feature that endows these
receptors with their death domain status is their intracytoplasmic domain called
the death domain. The death domain on the receptors interacts with the death
domains of the cytosolic proteins TRADD and FADD. In turn, their death effecter
domains interact with the death effecter domains of pro-caspase-8 thereby
causing its proteolytic autoactivation with the end result being active caspase-8
and thereby activation of the extrinsic apoptotic cascade. However, the intrinsic
pathway is the most likely progression for the constitutive cells in allograft heart
valves and thus will be given more attention throughout this Dissertation.
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2.6 THE MITOCHONDRIA AND CYTOCHROME C

Mitochondria are intracellular organelles whose primary role is to
manufacture ATP that fuels daily activities in the cell. Mitochondria are
0.5 - 1.0 urn in diameter and comprised of an outer membrane, an inner
membrane, an intermembrane space and the cristae formed from the folding of
the inner membrane and the matrix (97). The intermembrane space houses
cytochrome c, a water-soluble protein that is a pivotal molecule in the apoptotic
cascade (56). Cytochrome c is a highly conserved protein across species, has a
molecular weight of 12 kDa, has a net positive charge and is loosely bound to the
mitochondrial intermembrane space (56). Cytochrome c normally functions in the
respiratory chain by transferring electrons between Complexes III and IV;
however, in response to apoptotic stimuli, the mitochondrial permeability
transition pore is activated and opened by BAX, a pro-apoptotic Bcl-2 family
member, and cytochrome c is released from the mitochondrial intermembrane
space into the cytosol Once in the cytosol, cytochrome c complexes with
apoptosis protease activating factor (Apaf-1), procaspase-9 and dATP which
results in pro-caspase 9 being cleaved into its active form, caspase-9.
Procaspase-3 is activated by caspase-9 and commits the cell to completing the
apoptotic program (Figure 3 page 18), (42, 58 83).
Another key role for the mitochondria is maintenance of cell homeostasis.
Fundamental to this role, the mitochondria serves as a calcium buffer/reservoir
for the cell and plays a critical role, along with the endoplasmic reticulum in
storing and releasing calcium as needed by the cell to activate necessary
intracellular signaling pathways (98, 114). The mitochondria are also the cell's
sensor for abnormal changes in temperature, pH, osmolality, accumulation of
denatured proteins and other aberrant physiological events (49). Four examples
of these changes, which are relevant to cryopreserved allograft heart valves, are:
1) abnormal temperature fluctuations (37°C to 4°C to -195°C), 2) osmolality
changes (10% DMSO has an approximate osmolality of 2000 mOsm/kg HOH
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FIGURE 3. Schematic Representation of the Apoptotic Cascade.
Hypothermia causes changes in the permeability of the cell membrane allowing
extracellular calcium to enter the cell. The mitochondrion attempts to sequester
the calcium but is ultimately unsuccessful and results in increased permeability of
the mitochondrial outer membrane. This results in cytochrome c translocating
from the mitochondria intermembrane space into the cytosol. Cytochrome c, an
essential element in electron transport, forms a complex with Apaf-1, a protease,
which in turn activates procaspase 9, and initiates a cascade of downstream
caspases (caspase-3). The proteolytic activity of the caspases eventually results
in DNA fragmentation and cell death. Bcl-2 and Bcl-X can block the release of
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cytochrome c from the mitochondria; prevent activation of the caspase cascade
and ultimately apoptosis (44).

versus physiologic osmolality of 280-300 mOsm/kg), 3) accumulation of
denatured proteins as a result of the hypothermic insult and 4) influx of
extracellular calcium as a result of cell membrane damage from prolonged
hypothermic exposure.
Perturbations in normal physiology can cause the mitochondria to activate
the intrinsic apoptotic pathway (49, 56). The exact physiochemical manner in
which mitochondria detect internal abnormalities and connect them to executing
the apoptotic program is not understood. However, there is speculation that the
mitochondria may initiate the apoptotic program after detecting increases in
intracellular calcium (114,115). This apoptotic triggering mechanism may be
applicable to the proposed experimental system. Zachariassen et al
demonstrated that when cells experience prolonged hypothermic exposure it
results in increased membrane fluidity and increased permeability to extracellular
calcium as depicted in Figure 3 on page 18 (29).
Calcium influx, as a result of hypothermia, occurs as the phospholipid
membrane cools and its fluidity changes such that it becomes more permeable to
extracellular calcium. The concentration gradient favors calcium diffusing from
the extracellular to intracellular environment. There is a millimolar to micromolar
calcium gradient, extracellular to intracellular (29, 114). As a result of calcium
influx, the mitochondria functions to sequester the excess calcium and at certain
concentrations, pro-apoptotic signals begin within the mitochondria that initiate
the intrinsic apoptotic pathway through activation of the mitochondrial
permeability transition pore (MPTp). This pore allows for the free diffusion of ions
and cytochrome c into and out of the mitochondria (114). This release of
cytochrome c initiates a cascade of events that concludes in the execution of the
apoptotic program.
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Newmeyer et al. first described that the mitochondria played a key role in
apoptosis in a cell-free model (104). This research was followed by that of Liu et
al by using cell extracts, where it was demonstrated that cytochrome c could
activate the apoptotic-signaling cascade in vitro (33). They also demonstrated an
increase in cytochrome c concentration in the cytosol of apoptotic cells, which
supports the results of the research described herein. A more detailed
examination of how cytochrome c is release from the intermembrane space is as
follows and is focused on the anti-apoptotic proteins under investigation in the
research reported herein. The release of cytochrome c likely occurs due to the
removal or inactivation of the Bcl-2 family of anti-apoptotic proteins (Bcl-2 and
BCI-XL), which are housed in the inner mitochondrial membrane (54, 83, 96). The
Bcl-2 proteins form a pore that remains closed and regulates the opening of BAX
which covers and regulates another pore, termed the mitochondrial permeability
transition pore (MTPp). As long as both pores remain closed, cytochrome c
cannot escape (47).
A proposed mechanism is centered upon the balance of Bcl-2
homodimers versus BAX homodimers and the prevailing pair determines whether
the cell resists apoptosis or succumbs to apoptosis, respectively (94, 95, 96,
105). The exact mechanism of how this occurs, whether there is an upstream
protease that facilitates their inactivation, or another mechanism, is still to be
determined. Once cytochrome c is released it binds to the endoplasmic reticulum
causing stored calcium to be released into the cytosol and thus establishing a
positive feedback loop with the mitochondria to drive the apoptotic cascade
forward. Additionally, once in the cytosol cytochrome c binds to apoptotic
protease activating factor-1 (Apaf-1), and in the presence of dATP/ATP promotes
assembly of the apoptotasome. This large complex subsequently activates procaspase-9. Procaspase-9 contains a caspase recruitment domain (CARD) that is
utilized to moderate specific interactions with the CARD domain in Apaf-1 (48).
Consequently, procaspase-9 is cleaved, by an unknown mechanism, into its
active form caspase-9, and it cleaves and activates the key executioner caspase,
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caspase-3. Once caspase-3 is activated the cell has reached a point of no return
and is committed to programmed cell death.
An interesting phenomenon that impacts the research conducted for this
Dissertation is that, several studies have demonstrated that cells going through
apoptosis do not experience damage to their mitochondrial structures when
proteins are released from the mitochondrial intermembrane space. It was further
found that when cytochrome c was released from the mitochondria, the
mitochondria shrank rather than swelled (93). If caspase inhibitors were added to
the reaction, the cells were rescued and after growth factors were added the
mitochondria returned to their original size and cytochrome c content (49).
Another conclusion drawn from the Martinou research was that no irreversible
damage had occurred, such as rupture of the outer membrane. A subsequent
study to investigate the integrity of the inner mitochondrial membrane was
conducted by von Ahsen et al (50). They isolated mitochondria treated with BAX
or Bid and cells treated with UV radiation or staurosporin and depleted them of
their cytochrome c. The mitochondria retained a fully intact protein import
mechanism, which indicates that the mitochondrial transmembrane potential
(AH'm), ATP and the inner membrane were fully intact and functional. Only the
outer membrane was breached thereby allowing the passage of cytochrome c
from the mitochondria (50).
Therefore, it becomes readily apparent that mitochondria play key roles in
maintaining intracellular homeostasis and responding to physiological insults by
activating the apoptotic cascade. These functions are being performed in addition
to maintaining the capacity to produce the ATP necessary to successfully drive
the apoptotic program through to a successful conclusion to support the long
term viability of the organism.

2.7 BCL-2

Bcl-2 is an anti-apoptotic member of the larger family of Bcl-2 proteins that
regulate the permeability of the mitochondrial outer membrane. The family is
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coded by no less than 25 genes and contains anti-apoptotic and pro-apoptotic
members. Bcl-2 is a proto-oncogene encoded by a 230 kb gene that results in a
24-26 kDa protein which is localized to the mitochondrial, microsomal and
nuclear membranes within a diverse number of cell types, inclusive of aortic
smooth muscle cells (54). The mammalian gene, bcl-2, is a homologue to the
ced-9 gene in the nematode worm Caeriorhadbitis elegans (52). The human bcl2 gene can function in C. elegans, thereby indicating that control of apoptosis is a
highly evolutionarily conserved process (52).
Bcl-2 is a protein that prevents the apoptotic program from proceeding
forward by preventing the release of cytochrome c from the mitochondria (109).
Bcl-2 is theorized to inhibit apoptosis by binding to other Bcl-2 family of proteins
via their BH1/BH2/BH3 domains (53, 83, 84). These domains are comprised of a
helices in close proximity, which create hydrophobic pockets that are
presumptive areas where Bcl-2 family members interact with each other via
intercalation (54). The pro-apoptotic proteins, BAX and BAK, can
stoichometrically overwhelm Bcl-2 molecules by binding to them via their own
BH1/BH2/BH3 domains in the mitochondrial membrane thereby allowing
cytochrome c to escape from the mitochondria (55). Therefore, the group of
proteins with the most molecules present prevails. The expression of Bcl-2 can
promote cell survival by countering some but not all apoptotic stimuli (56). In
addition, bcl-2 is well known to be deregulated in tumor cells as a result of
translocation into the immunoglobulin heavy chain locus and as a result is
constitutively activated in B cell malignancies (57). Also, Bcl-2 has been
demonstrated to protect mammalian cells from DNA, RNA, and protein synthesis
inhibitors, and sodium azide, colchicines, steroids, heat shock and irradiation
(58).
Research has demonstrated that hypothermia enhances Bcl-2 expression
and protects against apoptotic death in Chinese hamster ovary cells (13). The
importance of these results to the research described herein is that it
demonstrates a link between hypothermic treatment and subsequent induction of
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the anti-apoptotic gene Bcl-2 which has the potential to prevent progression to
apoptosis by blocking release of cytochrome c from the mitochondria.
In summary, Bcl-2 like many of the other key elements in the apoptotic
cascade is highly conserved across species speaking to its importance in
contributing to cell homeostasis. Bcl-2 is essential in regulating the escape of
cytochrome c from the mitochondrial intermembrane space into the cytosol and,
as such, Bcl-2 is a key regulatory protein in the apoptotic cascade. Previous
research has indicated Bcl-2 is enhanced by hypothermic exposure which is
analogous to the test articles used during the research reported herein.

2.8 CASPASES

Caspases (cysteinyl-aspartic-acid- proteinases) are a family of cysteine
proteases that specifically cleave their substrates after aspartate residues. Their
targets are other pro-caspases in the apoptotic cascade as well as pro-apoptotic
proteins such as Bid. Two other pro-apoptotic proteins that caspases cleave are
poly (ADP-ribose) polymerase (PARP), a protein essential for DNA repair, and
gelsolin, whose active proteolytic products mediate some of the morphological
changes that occur during apoptosis and activation of the anti-apoptotic proteins
in the Bcl-2 family (58). The end result of this cascade is the characteristic
chromatin condensation, DNA laddering, cell shrinkage and formation of
apoptotic bodies that are associated with apoptotic cells.
Genetic analysis of the nematode Caenorhadbitis elegans (C. elegans)
has provided much data regarding apoptosis, the proteins that regulate
programmed cell death and how highly conserved this process has been
throughout evolution. Activation of two genes in particular, ced-3 and ced-4, have
been deemed essential for apoptosis in this nematode. Ced 3 was found to be
homologous to the human protein, 1(3-converting enzyme (ICE). A protein
resembling ICE is found in apoptotic cell extracts, prICE, and it cleaves
substrates known to be targeted during apoptosis, but it does not cleave prointerleukin-1p. Later it was determined that prICE was caspase-3 and it is
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responsible for the cleavage of PARP and the catalytic subunit of DNAdependent protein kinases. Both of these substrates have an aspartate (ASP)
residue in the Pi and P4 positions of the caspase-3 catalytic domain as their
recognition site. Mosser et al found that Hsp70 inhibits the transition from the
zymogen to active caspase-3, thereby inhibiting the progression of the apoptotic
program (59).
One of the hallmarks of caspases is their high degree of regulation, which
is necessary given their extraordinary capabilities. To that end, caspases exist in
most cell types as zymogens, an inactive form of an enzyme. Caspases are
cysteine proteases that have a minimum of 100 target substrates during
apoptosis (60). They cleave on the carboxyl side of the ASP residue and their
basic structure is similar. Each active caspases has an

tetramer comprising

two identical large subunits (17-22 kDa) and two identical small subunits (20-12
kDa). The zymogen form has an N-terminal prodomain, a large subunit and a
small subunit. Of the 12 main caspases, 7 are felt to be involved in apoptosis.
Caspases 3, 6 and 7 have been classified as effector caspases. Upon activation,
by being cleaved between their large and small subunits, they cleave most
known apoptotic substrates (60). Caspases 2, 8, 9 and 10 have been classified
as initiator caspases for the apoptotic program. The main difference between the
activator and the effecter caspases is effecter caspases have a homotypic
protein-protein interaction motif and a caspase activation and recruitment domain
(CARD) which contribute to the transduction of various signals into proteolytic
activity. Some of the basic regulatory strategies for caspases include selective
use of contact between the interacting protein domains which may take
advantage of hydrophobic interactions and allosteric changes in protein
conformation.
Procaspase-9 is specifically activated by the release of cytochrome c from
the mitochondria. Procaspase-9 is cleaved and activated which in turn cleaves
the zymogen form of caspase-3, and activates caspase-3 (61). Caspase-3
production is a milestone in the commitment of the cell to become apoptotic and
the junction between the intrinsic and extrinsic apoptotic pathways. In contrast,
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the external pathway is activated when the Fas receptor is cross linked, thereby
activating the death domains which result in the cleavage of the zymogen form of
caspase-8, activating it and allowing it to cleave procaspase-3 into active
caspase-3 (62). The activation of caspase-3 results in the commencement of
DNA cleavage by endogenous nucleases that result in cell shrinkage and the
formation of apoptotic bodies (62).
In summary, caspases are a highly conserved family of proteins across
species whose activities are tightly regulated post-transcriptionally, which is
indicative of how important and powerful they are. Left unchecked, they are
capable of bringing about the demise of their host. Hsp70 may be capable of
inhibiting pro-caspases from progressing to their active forms. Thus
augmentation of the Hsp70 response may help avert activation of the caspases
in allograft heart valve cells, thereby preventing progression of the apoptotic
cascade.

2.9 THE HEAT SHOCK RESPONSE AND APOPTOSIS

It has been experimentally demonstrated that constitutive over expression of
Hsp70 yields sustained protection from apoptosis (64). This is somewhat
paradoxical, as heat shock protein accumulation in ischemic cells has been
considered a hallmark of cell injury and viewed as a negative finding. Rather,
their presence should perhaps be considered indicative of the cells attempting to
survive the physiological insult. To support this, it has been demonstrated that
when Xenopus are microinjected with denatured proteins, heat shock protein
production is stimulated in response to the stress of accumulating denatured
proteins (65). In addition, oxidation of thiol groups in proteins as the result of
exposure to oxidizers and ischemia has been demonstrated to lead to protein
denaturation (107). Therefore, whether or not a cell goes through apoptosis after
being physiologically insulted may be a race between the ability of heat shock
proteins to repair the damaged intracellular proteins and the apoptotic program to
progress as the cells continue to receive apoptotic stimuli.
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Hsp70 has been demonstrated to inhibit the progression of the apoptotic
cascade (59). Polla and coworkers reported that the mitochondria might be the
target for heat shock induced protection against apoptosis from stress (66).
Recent research has demonstrated several points within the intrinsic apoptotic
cascade where Hsp70 acts as a negative regulator (Figure 4, page 27). Those
points of negative regulation are as follows: 1) inhibition of stress- activated
protein kinase pathway (SAPK/JNK) phosphorylation and subsequent activation
of transcription factors and caspases, 2) inhibition of pro-caspase-3
transformation into caspase-3 and committing the cell to apoptosis, 3) prevention
of cytochrome c release from the mitochondria by increasing the amount of Bcl-2,
4) competition for Apaf-1 binding sites on the apoptosome during recruitment of
pro-caspase-9 to the apoptosome, 5) interference with conversion of procaspase-3 to active caspase-3 and 4) inhibition of downstream of caspase-3,
potentially (53). In support of these potential regulatory points within the apoptotic
cascade, Li et a/I found that Hsp70 inhibited apoptosis downstream of the release
of cytochrome c and upstream of the activation of caspase-3 (42). These data
would point to caspase-9 being the Hsp70 target.
There is evidence that Hsp70 induction can be correlated with protection
against stress induced apoptosis (74, 75, 76, 77, 78, 79, 80, 81, 82). An
assertion made in this dissertation's hypotheses is that hypothermic
preconditioning (1-10°C incubation followed by 37°C incubation) prior to
cryopreservation will result in a significant increase in heat shock protein in the
cells. The presence of Hsp70 is hypothesized to decrease the quantity of proapoptotic proteins and the number of cell that are irreversibly apoptotic compared
to constitutive cells in tissues that do not undergo the preconditioning treatment.
Research conducted by Mosser et al. used an in vitro model to demonstrate that
cells, in which the expression of Hsp70 was either constitutively elevated or
inducibly elevated by a tetracycline-regulated transactivator, were resistant to
heat stress-induced apoptosis. They determined that cells induced to produce
elevated Hsp70 inhibited activation of stress-activated protein kinase
(SAPK/JNK). This nuclear pathway is implicated in apoptosis induction after
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ceramide treatment of cells. They were able to further elucidate that cleavage of
pro-caspase-3 to the active form, caspase-3, is inhibited in cells expressing
elevated Hsp70 and may at least partially account for inhibition of apoptosis,
(59).
Interestingly, Beere et al. demonstrated that Hsp70 is able to directly
inhibit caspase-9 processing by interacting with Apaf-1 to prevent the recruitment
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regulate the apoptotic cascade are as follows: 1) Inhibition of stress-activated
protein kinase pathway (SAPK/JNK) phosphorylation and activation of
transcription factors and caspases, 2) Inhibition of pro-caspase-3 transformation
into caspase-3 and committing the cell to apoptosis, 3) Prevention of cytochrome
c release from the mitochondria by increasing the amount of Bcl-2, 4)
Competition for Apaf-1 binding sites on the apoptosome during recruitment of
pro-caspase-9 to the apoptosome, 5) Inhibition downstream of caspase-3
activation potentially. (53)

of procaspase-9 to the apoptosome, (67,68). The apoptosome is a large protein
triggered to assemble upon release of cytochrome c from the mitochondria as a
result of cellular insult. The apoptosome is comprised of cytochrome c that binds
Apaf-1 (apoptotic activating factor 1) along with dATP. This complex then recruits
and transforms procaspase 9 from a zymogen to an active enzyme able to active
procaspase-3 and the apoptotic cascade (48).
Collectively, these data demonstrate multiple places where Hsp70 may act
to regulate the progression of the apoptotic cascade. It is most probable that
Hsp70 acts simultaneously at the multiple control points. Our current
understanding of cell physiology teaches that most systems have redundancy
and there is every reason the regulation of the apoptotic cascade should not be
an exception to the rule.

2.10 Summary

Apoptosis, and many of the key components in programmed cell death
such mitochondria, cytochrome c and caspases are highly conserved elements
across species and evolution. Hsp70 is also highly conserved across species
and time. The linkage between the two systems is being experimentally
established by many investigators along with the chronology of emergence of
each element in relation to the other. Hsp70 has been demonstrated to
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negatively regulate the apoptotic cascade in no less than four points. Glutamine
has been demonstrated to have a positive effect on the rate of Hsp70
transcription during heat shock. The research described herein seeks to build
upon the knowledge already gained in the field and add to it in a meaningful
manner.
It was a hypothesis of the current research that addition of Gin to allograft
heart valve disinfection media and subsequently heat shocking the mixture by
returning it to euthermic conditions (37°C) during disinfection would augment the
amount of Hsp70 in the constitutive cells. Elevation in the amount of Hsp70
present in the cells would prevent them from progressing to apoptosis as a result
of prolonged hypothermic insult and thus be viable at the time of implantation and
undergo normal cell turn over once in situ. The long term benefit to the patient
would be that the allograft heart valve would contain a viable cell population that
can renew and repair the extracellular matrix for prolonged durability and
resistance to calcification.
The results from the research described herein demonstrated that
supplementing the disinfection media with a final concentration of 10 mM Gin and
heat shocking the heart valve at 37°C during disinfection resulted in significant
increases in the amount of Hsp70 present in the cell, cytochrome c remained
localized in the mitochondria, Bcl-2 levels were augmented, caspase-3 levels
remained low and the constitutive cell population had reduced amounts of
apoptotic cells relative to the 4°C controls. There was no increase in Hsp70
observed when Gin supplementation was added to the 4°C disinfection treatment
group and thus it performed identically to the untreated 4°C control in that all of
the pro-apoptotic markers were elevated and anti-apoptotic markers were not
discernable. While there were positive results obtained when the tissues were
heat shocked without Gin, the optimal results, with respect to reducing the
number of apoptotic indices, were obtained when the cells were heat shocked in
the presence of Gin.
These results make it evident Gin and heat shock act synergistically to
halt the progression of the apoptotic cascade in constitutive allograft heart valve
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cells treated according to this regime by augmenting the amount of Hsp70
present. This could have a significant impact to the long term durability of
allograft heart valves that are used to save the lives of thousands of adults and
children annually.
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CHAPTER 3
MATERIALS AND METHODS

3.1 Reagents and Suppliers

Table 1. Reagents and Suppliers
Reagent

Supplier

Catalog Number

RPMI 1640

Hyclone

TXSH3A146502LN

Cryosolution

Hyclone

TXSH3A146702LN

Dimethylsulfoxide

Sigma

D2438

Lactated Ringers

B.Braun

R5410-01

Polymixin B

Bedford Laboratories

NDC55390-139-01

Cefoxitin

Merck

NDCC0006-3356-45

Vancomycin

Eli Lilly

NDCC0002-7297-01

Lincomycin

Pharmacia & Upjohn

NDCC0009-0555-02

Sterile water for injection
Glutamine

American Pharmaceutical NDCC63323-185-10
Partners, Inc.
Sigma
G7513

Glutamine Quantitation Kit

Sigma

GLN2

10% Buffered formalin

Sigma

HT501640

Liquid Nitrogen

Roberts Oxygen

RLN240

F12K Medium

ATCC

30-2004

HEPES

Sigma

H4034

TES

Sigma

T5691

Ascorbic acid

Sigma

A4403

Sigma

11884

Sigma

E9640

Insulin/Transferrin/Sodium
Selenite Cocktail
Endothelial Cell Growth
Supplement
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Table 1. Continued
Reagent

Supplier

Catalog Number

BCA Protein Assay

Pierce Chemical

23235

Ethanol

Fisher

HC-800

CitriSolve

Fisher

22-143-975

Paraffin

Fisher

P31-500

Hematoxylin

Richard Allen

7231

Eosin

Richard Allen

7111

Ultrmount

Dako

S1964

Active Motif

48506

Active Motif

40015

Caspase-3 antibody

R and D Systems

AF835

Retrievit-8

Biogenex

BS-1008-00

DAKO

K4008

Universal Blocking Solution

Dako

X-9090

CardioTacs TUNEL Kit

Trevigen

4827-30-K

Bcl-2 ELISA Kit

Oncogene

QIA23

Function ELISA™
Cytochrome c Kit
Mitochondrial Fractionation
Kit

Envision
Immunohistochemistry Kit

Hsp70 ELISA Kit

Stressgen Biotechnologies
Corp.

EKS-700

3.2 Aortic Heart Valve Conduit

Human aortic heart valve conduit was obtained from a tissue bank in
accordance with their standards for providing human tissue for scientific
research. All donor tissues had consent for research. All donors, ischemic times
associated with the donor tissue and handling of the tissue met the criteria set
forth by the American Association of Tissue Banks (AATB) and therefore the
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tissue utilized in this research mirrored the handling and acceptance criteria
applied to tissue deemed acceptable for clinical transplant. The tissue was
procured from tissue donors whose bodies were refrigerated within at least 15
hours of asystole, the heart aseptically recovered from the donor within 24 hours
of asystole and shipped to the tissue bank on sterile isotonic saline that was
maintained at 1-10°C. The aortic valves were dissected and placed into RMPI
1640 and held at 1-10°C until obtained by the researcher, 0.5 - 2.5 hours postdissection. The tissues were allocated to their respective treatment regime within
48 hours of asystole per AATB guidelines with respect to time. The tissue was
randomly assigned to an experimental group. The researcher was unaware of
the tissues' ischemic times, donor genders and donor ages until all of the
analyses were completed. This was done to avoid biasing the results.
The demographics of the donors are as follows: 5 females and 7 males
and the mean age of these donors are 44.3 years +/- 8.4. The mean ages for
each experimental group are listed in Table 2 below.

3.3 EXPERIMENTAL GROUPS

Three valve experimental treatment groups were followed throughout the
processing protocol to determine the effect of the experimental treatment on the
amount of heat shock protein present in the cells and apoptotic indices of the
cells over time, pre and post cryopreservation, relative to the standard
processing protocol, fourth group. The three experimental groups were traditional
antibiotic incubation method at 4°C supplemented with Gin; antibiotic incubation
method at 37°C; and antibiotic incubation method at 37°C supplemented with
Gin. The control group was the traditional antibiotic incubation method at 4°C.
The experimental system was human aortic conduit tissue.
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Table 2. Donor Demographics and Ischemic Times

Treatment

Average

Average

Average

Average

Group

Age (years)

Warm

Cold

Total

Ischemic

Ischemic

Ischemic

n=3

Times

Times

Time (hours)

per group

(hours)a

(hours) b

4°C

38.3 +/- 8.7

13.8 +/-3.0

12.8 +/-3.3

26.5 +/- 6.4

37°C

43.0 +/- 5.9

11.5+/-4.7

13.3+/-3.5

24.5 +/- 8.0

4°C + Gin

51.0+/-7.3

10.0+/-4.1

18.8+/-4.0

28.8 +/- 5.7

37°C + Gin

45.0 +/- 8.5

11.3+/-4.3

16.3 +/- 3.5

27.5 +/- 3.5

a

Warm ischemic time is the period of time from asystole until the heart is
removed from the donor and placed into cold, 1 -10°C, isotonic solution.

b

Cold ischemic time is the period of time from the heart being placed into
cold, 1 -10°C, isotonic solution at procurement until placement of
dissected heart valve tissues in antibiotics.

3.4 EXPERIMENTAL TIME COURSE

The target proteins, Hsp70, Bcl-2, cytochrome C, caspase-3 and apoptotic
state of the cells were quantitated during the 24 hour antibiotic incubation phase
and during the rewarming phase post-cryopreservation. During the antibiotic
incubation, samples were assayed at time zero and after 1, 2, 3, 4, 6 and 24
hours of incubation in the antibiotic solution. During the post-cryopreservation
incubation, samples were assayed at zero time post thawing and after 1,2,6, 24,
48 and 72 hours of in vitro incubation at 37°C. The entire experimental time
course is outlined in the flow diagram below.
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Flow Diagram of Experimental Scheme and Time Course

1. Donor asystole, initiation of warm ischemic time.

2. Donor placed in refrigerated morgue, initiation of cold ischemic time.

3. Heart and other tissues aseptically recovered in an operating room and transported to
tissue bank on wet ice in isotonic solution.

4. Heart valves dissected, distal aortic conduit placed in RMPI 1640 and transported on wet
ice to laboratory for testing.

5. Tissue incubated aseptically in antibiotic solution under conditions the tissue was
randomized to (4°C or 37°C and with or without Gin) which stops cold ischemic time.

6. Tissue removed from antibiotic solution after 0, 1,2, 3, 4, 6 and 24 hours of incubation
and placed in formalin or on dry ice waiting to be assessed, see box 9 below.

7. Remaining tissue cryopreserved and stored at <120 °C in vapor phase nitrogen for a
minimum of 72-hours.

8. Tissue aseptically thawed and diluted of cryoprotectant and placed in vascular smooth
muscle cell culture media at 37°C and 5% C02.

7. Tissue removed after 0,1,2, 6, 24, 48 and 72 hours of incubation for testing and placed in
formalin or on dry ice.

9. Assess the Hsp 70, cytochrome c, Bcl-2, caspase-3 content and TUNEL positivity of the
cells in addition to the protein content of the tissue extracts.

10. Samples for Hsp70, cytochrome c and Bcl-2 were crushed under liquid nitrogen and the
samples for caspase-3 and TUNEL staining were histologically prepared.
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3.5 ANTIBIOTIC SOLUTION PREPARATION

Polymyxin B Sulfate was prepared to a final concentration of 100 |j.g/ml,
Cefoxitin was prepared to a final concentration of 240 ^g/ml, Vancomycin was
prepared to a final concentration of 50 ng/ml and Lincomycin HCI was prepared
to a final concentration of 120 (ig/ml in RPM11640. The target Gin concentration
for the two Gin treatment groups was 10.5 mM, therefore an additional 8.5
mmoles of Gin was added (Kojima, 1998).

3.6 CRYOPRESERVATION

At the conclusion of the 24-hour antibiotic incubation the tissue was placed
in Teflon pouches with Cryosolution (RPM11640 and 10% fetal calf serum) such
that the total volume was 100 mL. Subsequently dimethylsulfoxide (DMSO)
cryoprotectant was added at a rate of 1% per 2 minutes, to a final concentration
of 10% to minimize osmotic shock in the aortic tissue constitutive cellular
population. The Cryosolution equilibrated in the tissue for two hours at 1-10°C.
The Teflon pouches containing individual allograft conduits were placed into
individual CryoSink® devices and placed into the freezing chamber so that the
long axis of the CryoSink was aligned with the liquid nitrogen fan diffuser. A
qualified thermocouple probe was inserted into the control pack, the control pack
was placed into a CryoSink device and the control pack was placed into the
freezing chamber. The double lead end of the thermocouple was plugged into the
freezing chamber receptacle and the door was closed and latched. A liquid
nitrogen line was securely attached to the CryoMed, the main liquid nitrogen
valve was opened and the cryopreservation process was initiated. The tissue
was cryopreserved by decreasing the temperature in the CryoMed by 1-2°C per
minute. Immediately following the conclusion of the cryopreservation process, the
CryoSinks containing the aortic conduits were placed into a liquid nitrogen
freezer in the vapor phase. The grafts were then removed from the CryoSinks
and placed into pre-conditioned fiberboard boxes for storage. The conduit tissue
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was stored in the LN2 vapor phase for at least 72 hours prior to further
experimentation.

3.7 THAWING AND DILUTIONAL REMOVAL OF CRYOPROTECTANT FROM
TISSUES

Each box of tissue was removed from the vapor phase of liquid nitrogen
and placed on the counter for seven minutes to slowly warm through the glass
transition phase. Subsequently, the tissue was removed from the fiberboard box,
and placed in a basin of sterile 37°C water and incubated for seven minutes. The
bath temperature was monitored and addition warm solution added as needed to
maintain the temperature between 37-42°C. In a laminar flow hood, the thawed
graft and Cryosolution were aseptically poured into the dilution basin, an
AlloFlow® chamber. A 1 L bag of room temperature Lactated Ringers was
suspended on an intravenous fluid pole located adjacent to the hood. Sterile
tubing connected the bag of Lactated Ringers to the AlloFlow chamber. The fluid
entered the chamber and initiated the dilutional removal of cryoprotectant from
the tissue. Once 250 ml of fluid entered the AlloFlow chamber, the chamber
began to drain into a sterile basin. The Lactated Ringers flowed into the chamber
over a period of seven minutes. Once the bag was empty and the AlloFlow
chamber stop draining, the tissue was removed from the AlloFlow chamber,
aseptically aliquoted into seven pieces for each time point. The zero time point
was portioned into a section that was placed into 10% buffered formalin and the
remainder was frozen on dry ice. The remaining six pieces were individually
placed into tissue culture flasks with 30 mis of media and stored at 37°C and 5 %
C02.
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3.8 MEDIA FORMULATION FOR IN VITRO INCUBATION

RPM11640 was supplemented with the following components as
prescribed by the American Type Culture Collection (ATCC) for the maintenance
of vascular smooth muscle cell line, CRL1999: 2mM glutamine, 10 mM 4-(2Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), 10mM 2-[(2-Hydroxy1,1-bis(hydroxymethyl)ethyl)amino]ethanesulfonic acid (TES), 0.05 mg/ml
ascorbic acid, 0.01 mg/ml insulin, 0.01 mg/ml transferrin, 10ng/ml sodium
selenite, 0.03mg/ml endothelial cell growth supplement and 10% fetal calf serum.
This media formulation was utilized to provide the vascular smooth muscle cells,
the primary resident cell population of the aortic conduit, with all the necessary
nutrients to maintain their viability. Therefore, if cells died during the 72 hour
incubation, it was a result of the cells not being able to recover from the
hypothermic transport, antibiotic disinfection process and/or the cryopreservation
process, rather than due to a lack of necessary nutrients. The media was not
changed during the 72-hour incubation as ATCC recommends changing the
media every 48-72-hours. The ratio of media to tissue surface area was held
constant.

3.9 GLUTAMINE QUANTITATION

Glutamine concentration in the RMP11640 disinfection media was assessed
using a glutamine quantitation kit from Sigma. The assay is based on the
reductive deamination of L-glutamine by Sigma's proprietary enzyme. The
assessment of L-glutamine is accomplished by linking a dye directly to the
reductive reaction. The reaction is specific for L-glutamine and does not crossreact with other amino acids or ammonia. The dynamic range of the assay is
0.25 mM to 6.0 mM L-glutamine; however, the sensitivity of the assay can be
increased beyond 0.25 mM by extending the incubation time. An internal
standard of L-glutamine was included in the assay to account for positive and
negative interference from the media components. The manufacture's
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instructions were followed to assay the amount of Gin in the antibiotic incubation
media.
Briefly, a 7-point Gin standard curve was prepared over the range of 0 mM to
6.0 mM Gin. The internal standard was prepared by adding an aliquot of
undiluted standard to an aliquot of RPMI1640. The test samples were prepared
by adding reaction buffer, sample and enzyme. The tubes were incubated for 1
hour in a 37°C waterbath. Subsequently color reagent was added to the tubes,
mixed and the samples were analyzed spectrophotometrically at 550 nm.
The L-glutamine concentration was calculated as follows. The slope of the
regression line from the standards was used to calculate the uncorrected Lglutamine concentration of the samples. The recovery of the internal standard
was used to correct the data obtained in the assay for deviations caused by the
interaction of media components with the test. The following formula was used to
calculate the recovery value:
1. Recovery = D = (A-B)/C
2. [L-glutamine] = mM concentration of L-glutamine
3. A = [L-glutamine] in sample with internal standard (spiked sample)
4. B = [L-glutamine] in sample without internal standard (unspiked
sample)
5. C = [L-glutamine] added as internal standard.
The concentration of L-glutamine in the samples was corrected for any
inhibition/enhancement using the recovery value of the internal standard
calculated above according to the following formula:
1. [L-glutamine] Corrected = E/D
2. D = Recovery value previously calculated
3. E = [L-glutamine] uncorrected in unspiked sample calculated from
the standard curve.
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3.10 PIERCE BCA PROTEIN ASSAY

The protein concentration in the extracts for all the ELISAs was
determined using the Pierce BCA Assay. A standard curve ranging from 0.02
mg/ml to 2.0 mg/ml was utilized to calculate the concentration of protein in the
experimental samples. The assays were performed in a microplate, therefore the
sample and standard volumes were 20 pi and the working reagent (1 part
reagent A and 49 parts reagent B) volume was 200 pi per sample. Once the
samples, standards and working reagent were added to the microplate, it
incubated at 37°C for 30 minutes and then the optical density of the solution was
assessed on an ELISA plate reader at 570 nm. A standard curve was generated
by performing a linear regression analysis of the bovine serum albumin (BSA)
standards to obtain the slope equation and the correlation coefficient. The BSA
standards were made in the buffer or solution that the samples were in for the
specific assay. The resultant optical densities of the standards diluted with buffer
from each kit was compared to the optical density of standards diluted with
ultrapure water to assure there was no positive or negative interference with
protein quantitation. The coefficient of variation was calculated for all the slopes
and the correlation coefficients are listed in the applicable results section.

3.11 PREPARATION OF AORTIC CONDUIT TISSUE FOR HISTOLOGICAL
ANALYSIS

The aortic conduit samples were fixed in 10% neutral buffered formalin
(1:10 w/v) for a minimum of 48 hours at 4°C prior to processing. The samples
were dehydrated, cleared and infiltrated with paraffin as follows. Each piece of
tissue was placed in a cassette and the cassette was labeled with a pencil. The
tissue cassettes were placed in 70% ethanol for 30 minutes (1-30 cassettes, 500
ml; 30-60 cassettes, 1.0 L), in a second bath of 70% ethanol for 30 minutes, in
95% ethanol for 30 minutes, in a second bath of 95% ethanol for 30 minutes, in
100% ethanol for 30 minutes, in a second bath of 100% ethanol for 30 minutes,
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in a third bath of 100% ethanol for 30 minutes, in paraffin: CitriSolve (1:3) for 60
minutes at 60°C, in paraffin: CitriSolve (1:1) for 60 minutes at 60°C, paraffin:
CitriSolve (3:1) for 60 minutes at 60°C and in 100% paraffin overnight at 60°C.
Subsequently they were embedded according to the following protocol.
Tissue cassettes were placed in the cassette warmer on the Tissue Tek
embedding center (or in a 60°C water bath) to prevent the infiltrated paraffin from
solidifying. An appropriately labeled (using pencil) embedding cassette was
placed on top of a base mold. The mold/cassette unit was placed on the warm
portion of the Tissue Tek embedding center. The mold/cassette unit was filled
with paraffin and a pair of forceps was used to remove the tissue from its
cassette and place it at the bottom of the mold on the thin edge such that cross
sectional (the adventitia, media and intima) samples would be obtained. The
mold was transferred to the cold plate and the cold forceps were used to hold the
tissue in the desired orientation until solidification began (approximately 10
seconds). After the paraffin began to solidify in the mold the unit was transferred
to an ice bath to complete the solidification process. The base molds were
separated from the paraffin blocks for sectioning. The paraffin blocks were stored
at 4°C and were sectioned a minimum of 24 hours post embedding according to
the following protocol.
The block was secured in the microtome chuck and a disposable blade
was placed in the blade holder. The position of the block was positioned to
ensure that it cleared the knife. Thick sections, 20 (im, were initially cut to ensure
the blade was cutting the paraffin evenly and to travel quickly into the block to
obtain representative samples. Once the blade was sufficiently advanced into the
specimen, the microtome was set to cut 9 pm sections. The resultant ribbons
were placed in a 50°C flotation bath using a warmed metal probe. The sections
were allowed to remain in the water bath until they were flat and devoid of
wrinkles and air bubbles. Then a positively charged glass microscope slide was
slid under the ribbon and raised from the water bath and placed on a slide
warmer to properly affix to the slide. Heat fixation was crucial as no gelatin was
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used in the bath to minimize background staining for the immunohistochemical
procedures.
To deparaffinize the slides prior to staining, the slides were placed in
CitriSolve for 3 minutes and repeated two more times, in 100% ethanol for 3
minutes, then 95% ethanol for 3 minutes, 70% ethanol for 3 minutes and water
for three minutes and repeated two more times.

3.12 CYTOCHROME C QUANTITATION

To assess cytochrome c content of mitochondria in aortic conduit cells, a
cytochrome c sandwich ELISA kit was used. Extraction of cytochrome c from
aortic conduit tissue was performed using a Mitochondrial Fractionation Kit and
subsequently quantitated using a FunctionELISA™ Cytochrome c kit, both
obtained from Active Motif North America. The Mitochondrial Fractionation kit
separates the mitochondria from the cytosol by chemical means and differential
centrifugation. The FunctionELISA™ Cytochrome c ELISA plate is pre-coated
with anti-cytochrome c antibody and thereby facilitates the detection of
cytochrome c in the mitochondrial and cytosolic fractions obtained during the
fractionation process. The kit has a dynamic range of 0.781 to 50 ng/ml of
cytochrome c and is able to detect human cytochrome c.
Sample preparation for the Mitochondrial Fraction kit was performed
according to manufacturer specifications for tissues. What follows is the tissue
protocol to separate the tissue into cytosolic and mitochondrial fractions using the
Mitochondrial Fractionation Kit. Tissue which had previously been snap frozen
was crushed using liquid nitrogen in a motor and pestle suited for liquid nitrogen.
The tissue was ground into a fine powder and collected into a cold
microcentrifuge tube in 50 mg aliquots, labeled and held at -80°C until extraction.
The extraction process was as follows. Ice cold cytosolic buffer, a
detergent based kit component, supplemented with a protease inhibitor cocktail
supplied with the kit, was added to each microcentrifuge tube at a ratio of 1 ml
per 50 mg of crushed tissue. The tubes were incubated on ice for 15 minutes to
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facilitate cell extraction and lysis. The samples were subsequently centrifuged at
800 x g, at 4°C for 20 minutes to separate the cytosolic lysate from the tissue
remnants. The supernatants were transferred to fresh pre-chilled microcentrifuge
tubes and centrifuged a second time at 800 x g, at 4°C for 10 minutes to remove
any residual nuclear debris. The supernatants were transferred to a fresh prechilled microcentrifuge tubes and centrifuged at 10,000 x g, at 4°C for 20 minutes
to separate the mitochondria from the cytosol. The supernatant, cytosol, was
transferred to fresh pre-chilled microcentrifuge tubes and held at 4°C until
needed for the BCA assay. The remaining pellets were washed with 100 pi
Complete Cytosolic Buffer by centrifuging them at 10,000 x g for 10 minutes at
4°C. The resulting supernatant was discarded. The mitochondrial pellet was
lysed by the addition of 100 pi of Complete Mitochondria Buffer; a detergent
based kit component supplemented with dithiothreotol (DTT) and protease
inhibitors, and subsequently incubated on ice for 15 minutes. After the incubation
was complete, the samples were vigorously vortexed for 10-15 seconds to
rupture the mitochondria. The protein concentration of the cytosolic and
mitochondrial fractions was then obtained using the Pierce BCA assay, section
3.10. The remaining cytosolic and mitochondrial samples were frozen and held at
-80°C awaiting the ELISA.
To determine the amount of cytochrome c in the cytosolic and
mitochondrial fractions, the Function ELISA™ Cytochrome c kit was utilized. The
manufacturer's protocol was followed as described herein. The samples did not
need to be diluted as their protein concentration was within the range specified
for the assay, 20-100 mg/ml. One hundred microliter aliquots of the well mixed
mitochondrial and cytosolic extracts were added to the anti-cytochrome c precoated microplates in triplicate. The samples were incubated for two hours at
room temperature with slow rocking. The plates were washed 3 times with 250 pi
of room temperature wash buffer, a detergent based solution supplied with the
kit. The cytochrome c antibody supplied with the kit was diluted 1:1000 with room
temperature blocking solution and 100 pi was added to each well. The plate was
incubated for one hour at room temperature with rocking. At the conclusion of
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the incubation the plate was washed 3 times with 250 pi of room temperature
wash buffer. Subsequently, the streptavidin horseradish peroxidase conjugate,
supplied with kit, was diluted 1:1000 in room temperature blocking buffer and 100
pi was added to each well. The plate was incubated at room temperature with
rocking for 1 hour. Cytochrome c was visualized upon addition of 100 pi of room
temperature tetra-methylbenzidine (TMB) substrate, supplied with the kit, to each
well. The plates were incubated statically in the dark for 10 minutes at room
temperature. The reaction was halted after 10 minutes by the addition of 50 pi
0.5 N sulfuric acid, supplied with the kit. The sulfuric acid stop solution was
added to the samples in the same order that the TMB reagent was added. The
optical density of the solution in the wells was determined using a microplate
reader and the 450 nm filter. The absorbance was proportional to the amount of
cytochrome c present in the sample. The results were determined from a
standard curve that was run concomitantly with the samples, 0.781 ng/ml to 50
ng/ml. The results were expressed as nanograms of cytochrome c per milligram
protein relative to the standard curve. By expressing the result per mg of protein,
the amount of cytochrome c was normalized for each sample.
To determine recovery and if a substance in the tissue extract was
causing positive or negative interference in the assay, three samples were spiked
with 12.5 ng of recombinant cytochrome c and their companion samples were not
spiked. The expected value (non-spiked sample concentration + known amount
of cytochrome c) minus the calculated concentration of the spiked sample divided
by the expected value multiplied by 100 was the percent recovery.

3.13 CASPASE-3 IMMUNOHISTOCHEMISTRY

The presence of active Caspase-3 in the aortic tissue constitutive cells
was detected immunohistochemically. To detect caspase-3 in aortic conduit
tissue sections, an antibody suitable for immunohistochemistry of formalin fixed,
paraffin embedded samples was obtained from R and D Systems. The antibody
was rabbit anti-human/mouse active Caspase-3. Standard immunohistochemical
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procedures were utilized. Briefly, tissue was fixed in 10% buffered formalin for 48
hours, dehydrated, cleared and infiltrated with paraffin, embedded and sectioned
at a thickness of 9 pm and mounted on positively charged slides without the use
of gelatin. Samples were taken from the first, middle and last third of the block to
obtain representative samples of the tissue. The slides were then deparaffinized
and rehydrated as outlined in chapter 3.11. To reveal the caspase-3 antigenic
sites that may have been masked by formalin fixation, the samples were
subjected to a target retrieval protocol.
The samples were placed in Retrievit-8, target retrieval solution from
Innogenex, and placed in the microwave and treated on high power for 1 minute,
then 20% power for 20 minutes and then cooled for 20 minutes at room
temperature. The endogenous peroxidases were quenched to prevent possible
false positives reactions by using the peroxidase blocking reagent supplied with
the immunohistochemistry kit. The peroxidase blocking reagent, 50 pi, was
applied to the samples and allowed to incubate at room temperature for 5
minutes, subsequently washed away using a room temperature phosphate
buffered saline bath for 5 minutes followed by an additional 5 minute incubation
at room temperature in a room temperature water bath. The slides were then
incubated with 50 pi of Universal Blocking Solution (Dako Envision
Immunohistochemistry Kit) for 20 minutes at room temperature. Subsequently,
the slides were incubated with 50 pi of the optimal concentration of caspase-3
antibody (10 pg/ml). The slides were incubated for 30 minutes at 37°C in a
humidity chamber, rinsed in a room temperature phosphate buffered saline bath
at for 5 minutes followed by an additional 5 minutes at room temperature in a
waterbath. This was followed by incubation at room temperature in a humidity
chamber for 30 minutes with 50 pi of peroxidase labeled polymer, a kit
component. The polymer was comprised of mouse and rabbit Fab' fragments
conjugated together using the peroxidase. After incubation, the slides were
rinsed in a phosphate buffered saline bath at room temperature for 5 minutes
followed by an additional 5 minutes at room temperature in a water bath.
Subsequently, the slides were incubated with 50 pi of 3-Amino-9-ethylcarbazole,
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AEC, chromagen substrate, a kit component, for 10 minutes at room
temperature, rinsed in a phosphate buffered saline bath at room temperature for
5 minutes followed by an additional 5 minutes at room temperature in a water
bath. The samples were counterstained in Mayer's Hematoxylin (Lillie
modification), for 5 minutes, rinsed, in room temperature water for 3 minutes,
after which an aqueous mounting media was applied along with a coverslip and
the histology slide was observed under a light microscope.
A positive and negative control slide was also carried through the
immunostaining to detect any nonspecific binding of antibody to non-target
antigenic sites within the histological section and ensure the antibody was
detecting the target antigen. The controls were processed as described above
with the exceptions detailed in the text that follows. The negative control sample
was generated by omitting the primary antibody to facilitate detection of non
specific secondary antibody Fab' fragment binding. Only antibody diluent was
used during this incubation step. The positive control was an aortic tissue section
known to contain apoptotic cells and treated identically to the experimental
samples.
The caspase-3 slides were subjected to thresholding. The number of
caspase-3 positive cells was determined by using an image analysis program,
Scion Image 4.0.2 software, NIH, using the thresholding function. The images
were captured using Spot Advanced 4.0.1 software, Diagnostic Instruments, Inc.
The image was visualized on the computer screen by double clicking the cursor
on the "Live" icon on the computer screen. To capture the image, the F9 key on
the keyboard of the computer was depressed. To resize the image, "Edit" was
selected on the task bar the "Resize" option was selected and the image was
resized to 50% of original size. Once the file was saved in TIFF format the image
was ready to undergo thresholding.
The result was determination of the number of cells in every other field of
the H&E slides using the 10X objective. Subsequently, the number of caspase-3
positive cells was determined in approximately the same fields of view. The
thresholding was performed as follows. The image from the microscope was
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captured as an uncompressed TIFF. The TIFF image was opened and the black
and white image was selected for analysis. Under the Process menu, Smooth
was selected to reduce the effects of background staining. Next, under the
Process menu, Sharpen was selected to increase the contrast of the target
components against the background. This may have been done twice,
depending on the clarity of the target component within the image. In the Map
window, the bottom right icon was selected. The scale labeled 'B' was used to
adjust the contrast of the image so that only the target components were visible.
In the Process menu, Binary was selected, to exclude the gray scale from the
image and to transform all the pixels into black or white. In the Process menu,
Binary, Erode was selected to separate two or more objects that appeared as
one. This may have been done twice, depending on the amount of remaining
non-target components. In the Analyze menu, Analyze Particles was selected. In
the Particle Analysis window, the Minutes Particle Size was set to 1, and the
Max. Particle Size was set to 150. Next, 'Label Particles' and 'Reset
Measurement Counter' were selected followed by ok. The Info window contained
'Count= X.' Where "X" was the number of target components in the image. The
number of caspase-3 positive cells was divided by the number of total cells and
multiplied by 100 to provide the percentage of caspase-3 positive cells in the
tissues.
These results were then statistically analyzed, see Chapter 3.18, to
determine if there was a statistically significant difference in caspase-3 positive
cells between the four treatment groups.

3.14 TUNEL STAINING

A common method used to analyze DNA laddering is the Terminal
Deoxynucleotide Transferase uNTP Nick End Labeling assay, TUNEL.
Detection of DNA laddering was performed in aortic conduit tissue sections by
using the CardioTacs TUNEL kit available from Trevigen. Detection of nuclear
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DNA fragmentation is a widely accepted method to assay for apoptosis and can
be performed in situ.
Briefly, tissue was fixed in 10% buffered formalin for 48 hours, dehydrated,
cleared and infiltrated with paraffin, embedded and sectioned at a thickness of 9
|jm and mounted on positively charged slides without the use of gelatin. Samples
were taken from the first, middle and last third of the block to obtain a true
representative sample of the tissue. The slides were then deparaffinized and
rehydrated as outlined in chapter 3.11. The manufacturer's instructions were
followed.
The samples were washed for ten minutes in room temperature
phosphate buffered saline. Subsequently the tissue was permeabilized by
addition of 50 pi of Cytonin, a kit component, for ten minutes at room
temperature. The slides were washed twice in an deionized water bath for two
minutes each at room temperature. Following this, the samples' endogenous
peroxidases were quenched by incubating the samples in a mixture of methanol
and 3% hydrogen peroxide at room temperature for five minutes. The quenching
step was followed by a one minute wash in deionized water at room temperature.
To prepare the slides for labeling, they were incubated in 1X TdT Labeling Buffer,
supplied with the kit, for 5 minutes at room temperature. Subsequently each
sample had 50^1 of Labeling Reaction Mixture (biotinylated
deoxynucleotidylphosphates (dNTP), terminal deoxynucleotidyl transferase (TdT)
and manganese, supplied with the kit) added to each of tissue, minimum of two
sections per slide, and was incubated at 37°C for 60 minutes in humidity
chamber. During this time, any nicks in the DNA at the 3' hydroxyl groups,
characteristic of apoptotic cells, were targets for the TdT to add the biotinylated
dNTPs to. Once the labeling reaction was complete it was halted by incubating
the slides in room temperature 1X Stop Buffer, supplied with the kit, for five
minutes. This was followed by two washes in room temperature deionized water
for five minutes each. Strepavidin conjugated to horseradish peroxidase (HRP),
supplied with the kit, was utilized to detect the nicked DNA in the cells via the
biotin labeled dNTPs. To accomplish this, 50 pi of strepavidin-HRP conjugate
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was added to each tissue section of interest. The samples were incubated at
room temperature in a humidity chamber for ten minutes. At the conclusion of the
incubation, the samples were washed three times for two minutes each in room
temperature deionized water. Subsequently, the complex was visualized upon
addition of 50 pi of TACS Blue, tetra-methylbenzidine (TMB), substrate that forms
a blue precipitate upon reaction with its enzyme, HRP. At the conclusion of the
ten minute incubation the samples were washed three times for two minutes
each in room temperature deionized water. To visualize the nuclei in the tissue,
regardless of their condition, the samples were incubated for 30 seconds in room
temperature Nuclear Fast Red, a kit component. The samples were then dipped
ten times in each of the following solutions: deionized water, 95% alcohol, 100%
alcohol and p-xylene. At the conclusion of the incubations, the slides were coverslipped with Ultrmount and stored in the dark until analysis as the TACSBlue is
light labile.
The positive and negative controls were tissues that had received no
pretreatment prior to assaying them. To generate the positive and negative
controls, 50 pi of nuclease was added to induce nicks in the 3' hydroxyl groups of
the cells' DNA and the slides were incubated for 15 minutes in a humidity
chamber at 37°C. At the conclusion of the incubation the samples were washed
for 5 minutes in a waterbath at room temperature. The positive control slide was
then processed identically to the experimental samples to ensure the assay was
working properly. The negative control slide received similar treatment with the
exception that the TdT was omitted to prevent the addition of the dNTPs and thus
the colorimetric response. The purpose of this slide is to ascertain nonspecific
interaction of the strepavidin with the tissue.
The number of TUNEL positive cells was determined by using an image
analysis program, Scion Image 4.0.2 software, NIH, and the thresholding
function. The images were captured using Spot Advanced 4.0.1 software,
Diagnostic Instruments, Inc. The result was determination of the number of cells
that were TUNEL positive relative to the number of cells on the companion H&E
slide. To accomplish this task the following steps were taken. The image was
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visualized on the computer screen by double clicking the cursor on the "Live"
icon on the computer screen. To capture the image, the F9 key on the keyboard
of the computer was depressed. To resize the image, "Edit" was selected on the
task bar the "Resize" option was selected and the image was resized to 50% of
original size. Once the file was saved in TIFF format the image was ready to
undergo thresholding.
To initiate the thresholding, the number of TUNEL positive cells was
determined in approximately the same fields of view as the companion H&E slide
preparations. The image from the microscope was captured as uncompressed
TIFF using Spot Advanced software. The TIFF image was opened and the black
and white image was selected for analysis. Under the Process menu, Smooth
was selected to reduce the effects of background staining. Next, under the
Process menu, Sharpen was selected to increase the contrast of the target
components against the background. This may have been done twice,
depending on the clarity of the target component within the image. In the Map
window, the bottom right icon was selected. The scale labeled 'B' was used to
adjust the contrast of the image so that only the target components were visible.
In the Process menu, Binary was selected, to exclude the gray scale from the
image and to transform all the pixels into black or white. In the Process menu,
Binary, Erode was selected to separate two or more objects that are appear as
one. This may have been done twice, depending on the amount of remaining
non-target components. In the Analyze menu, Analyze Particles was selected. In
the Particle Analysis window, the Minutes Particle Size was set to 1, and the
Max. Particle Size was set to 150. Next, 'Label Particles' and 'Reset
Measurement Counter' were selected followed by ok. The Info window contained
'Count= X.'. This was the number of target components in the image. The
number of caspase-3 positive cells was divided by the number of total cells and
multiplied by 100 to provide the percentage of TUNEL positive tissues.
These results were then statistically analyzed; see Chapter 3.18, to
determine if there is a statistically significant difference in TUNEL positive cells
between the four treatment groups.

51

3.15 IMAGES

Images were obtained using an Olympus BX41 microscope, SPOT insight
color camera and their size reduced by using SPOT Advanced image analysis
software, version 4.0.1 by Diagnostic Instruments, Inc.. The images were
obtained using the 4x and 10x objectives and reduced in size by 50 percent
using the resize function in the software.

3.16 BCL-2 QUANTITATION

Bcl-2 ELISA kits were obtained from Oncogene to detect the presence of
Bcl-2 in the conduit tissue. The kit is designed to detect Bcl-2 in tissue extracts
and has a dynamic range of 0 - 200 U Bcl-2/ml. One unit of Bcl-2 equals the Bcl2 activity in 5.6 X 104 HL-60 cells.
Sample preparation was according to manufacturer's instructions and is
briefly described. Tissue that was flash frozen during the experimental time
course was subsequently ground in the presence of liquid nitrogen using a
mortar and pestle. Once a fine powder was achieved it was removed and placed
into a pre-chilled microcentrifuge tube and stored at -80°C until needed for
extraction. To extract Bcl-2 from the tissue, antigen extraction solution included in
the kit was added at a ratio of 1 ml per 50 mg tissue. The tissue was incubated
on ice for 30 minutes, vortexed every 10 minutes, and centrifuged at 800 x g at
4°C for 10 minutes to pellet the tissue debris. The protein concentration of the
cell extracts (supernatant) was determined using the Pierce BCA protein assay
(chapter 3.10) prior to freezing the extract.
The ELISA was performed as follows. The samples were diluted 1:25
(w/v) in sample diluent, kit component, and mixed well. Subsequently 50 pi of
diluted sample was added to the plate in triplicate along with 50 pi of Bcl-2
detector antibody (FITC-conjugated monoclonal anti-human Bcl-2 antibody),
standards (5.12 - 200 U/ml) and blanks. The plates were incubated for two hours
with rocking at room temperature. Subsequently they were washed 3 times with
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250 pi of phosphate buffered saline at room temperature. Conjugate (rabbit antiFITC peroxidase conjugate, kit component) was diluted 1:200 using Conjugate
Diluent, kit component, and 100 pi of diluted sample was added to the plate. The
plates were incubated for 30 minutes at room temperature with rocking. After the
incubation was complete, the plates were washed 3 times with 250 pi of room
temperature phosphate buffered saline. An additional wash was performed by
flooding the plate with room temperature deionized water. One hundred
microliters of tetra-methylbenzidine (TMB) substrate, kit component, was added
to each sample and the plates were statically incubated for 30 minutes in the
dark at room temperature. The reaction was halted upon addition of 100 pi of 2.5
N sulfuric acid, kit component, and subsequently the samples were read at 450
nm on a plate reader. The sulfuric acid was added to the samples in the same
order that the TMB reagent was added. The results were expressed as Units of
Bcl-2 per milligram protein as calculated from the Bcl-2 and protein standard
curves.
To determine percent recovery and if a substance in the tissue extract was
causing positive or negative interference in the assay, three samples were spiked
with 100 U of recombinant Bcl-2 and their companion samples were not spiked.
The expected value (non-spiked sample concentration + known amount of Bcl-2)
minus the calculated concentration of the spiked sample divided by the expected
value multiplied by 100 was the percent recovery.

3.17 HEAT SHOCK PROTEIN 70 QUANTITATION

Hsp70 ELISA kits were obtained from Stressgen Biotechnologies
Corporation to detect the inducible form of Hsp70 present in the human aortic
conduit tissue samples. The kit is designed to detect Hsp70 in tissue extracts and
has a dynamic range of 0.78 to 50 ng/ml.
Sample preparation and assay performance was executed according to
manufacturer instructions. Tissue that was flash frozen during the experimental
time course was subsequently ground in the presence of liquid nitrogen in a
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mortar with a pestle. Once a fine powder was achieved it was removed from the
mortar. Extraction buffer and protease inhibitor cocktail, kit components, were
added (0.1 g powder /1 ml of extraction buffer supplemented with protease
inhibitor), and the tissues were vigorously vortexed and incubated on ice for 30
minutes with occasional vortexing. Subsequently the tissue extract was
centrifuged at 21,000 x g for 10 minutes at 4°C. The supernatant was collected
and the supernatant protein concentration was determined using the
commercially available Pierce, BCA protein assay kit and the remainder of the
sample was frozen at minus 80 awaiting quantitation.
The quantitative ELISA utilizes a mouse monoclonal antibody specific for
inducible Hsp70. The 96-well plate was pre-coated by the manufacturer with
inducible anti-Hsp70. One hundred microliters of samples, in triplicate, and
standards (0.78 - 50 ng/mL) were added to the 96-well plate and incubated for
two hours at room temperature with rocking. Subsequently the plate was washed
6 times with 250 pi room temperature phosphate buffered saline. The antigen
was detected by addition of 100 pi biotinylated rabbit anti-inducible Hsp70
polyclonal antibody diluted 1:500 in biotin anti-Hsp 70 diluent, all kit components,
according to manufacturer's instructions. The plates were incubated 1 hour at
room temperature with rocking, and subsequently washed 6 times with 250 pi of
phosphate buffered saline at room temperature. Next, 100 pi of avidinhorseradish peroxidase conjugate, diluted 1:11,000 in avidin-horseradish
peroxidase conjugate diluent, both kit components, was added and the plate was
incubated for 1 hour at room temperature. The plate was washed 6 times with
250 pi of room temperature phosphate buffered saline. The plate was developed
by addition of 100 pi of tetramethylbenzidine substrate (TBM) and a blue color
developed in proportion to the amount of Hsp70 that was present after incubating
for 10 minutes at room temperature. The color development was stopped by
addition of 100 pi of sulfuric acid stop solution, causing the color to become
yellow. The amount of Hsp70 detected was determined by analyzing the solution
in the wells spectrophotometrically at 450 nm. The results were expressed as
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nanograms of Hsp70 per milligram protein relative to the Hsp70 and protein
standard curves.
To determine recovery and if a substance in the tissue extract was
causing positive or negative interference in the assay, three samples were spiked
with 12.5 ng of recombinant Hsp70 and their companion samples were not
spiked. The expected value (non-spiked sample concentration + known amount
of Hsp70) minus the calculated concentration of the spiked sample divided by the
expected value multiplied by 100 was the percent recovery.

3.18 STATISTICAL ANALYSIS

A one factor analysis of variance, ANOVA, statistical test was performed
to determine if there was a statistically significant difference between the various
treatments groups and their ability to induce Hsp70 and Bcl-2 production, to
inhibit leakage of cytochrome C from the mitochondria, to inhibit Caspase-3
formation and to inhibit the formation of apoptotic cells. A Tukey HSD test was
performed to determine which groups were statistically significantly different from
the others. Lilliefors test was performed to ensure the data were normally
distributed.
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CHAPTER 4
RESULTS

4.1 DONOR VARIABLES

Ari ANOVA was performed, at the 95% confidence interval, to determine if
there was a statistically significant difference between the age of the donors, the
warm ischemic time of the tissue, the cold ischemic time of the tissue and the
total ischemic time of the tissue. A significant difference could bias the data
obtained from the donor tissues. There were no statistically significant
differences between the ages of the donors (p = 0.188), the warm ischemic times
of the donors (p = 0.651), cold ischemic times of the donors (p = 0.179) and total
ischemic times of the donors (p = 0.794).

4.2 PROTEIN CONCENTRATION OVER TIME

Protein concentration over the experimental time course was investigated
to confirm there were no fluctuations. Protein content was utilized to normalize
the results for all of the ELISA studies to quantitate Hsp70, cytochrome c and
Bcl-2. Therefore significant fluctuations over time in protein content could have
falsely elevated or reduced the target protein concentration and impacted the
validity of the conclusions derived from the data. To demonstrate that the protein
content of the tissue and resultant extracts did not decrease over time, the
results of the BCA protein assay were plotted and analyzed over time (Figure 5).
The results for each time point in Figure 5 are the average and resultant standard
deviation for all four tissue extracts from three independent experiments, each
with two or three replicates. This graph demonstrates the constancy of the
protein concentration in tissue over the 24 hour and 72 hour incubations as the
slope of the line is approximately zero, -0.0018. Thus, the results presented
herein are the result of alterations in the target protein
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FIGURE 5. Protein concentration in aortic conduit samples over time. The
linear regression analysis demonstrates the protein values approximate a straight
line and therefore, there was not an appreciable variability in the protein
concentration in the samples over time. The Pierce BCA assay was utilized to
quantitate the amount of protein in cell and/or tissue lysates for the cytochrome c
(mitochondrial and cytoplasmic extracts), Bcl-2 and Hsp70 ELISA assays. The
protein values were used to normalize the target protein concentration per
milligram of protein.
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concentration and not due to decreased amounts of protein, due to proteolysis, in
the extracts that may falsely elevate or reduce the target protein concentration.
The optical densities for BSA standards diluted with each assay buffer
were compared to the optical density of BSA standards diluted with ultrapure
water and found to not be statistically significantly different at each concentration,
p > 0.05. Therefore none of the assay buffers had a positive or negative effect on
the outcome of the BCA assay and thus did not affect the outcome of the Hsp70,
cytochrome c and Bcl-2 ELISA assay results.
4.3 GLUTAMINE CONCENTRATION

To determine the amount of Gin in the RMPI 1640 incubation media a
quantitative Gin assay was performed. The assay is based on the reductive
deamination of L-glutamine by Sigma's proprietary enzyme. The assessment of
L-glutamine is accomplished by linking a dye directly to the reductive reaction.
The reaction is specific for L-glutamine and does not cross-react with other
amino acids or ammonia. The average Gin concentration in RPMI 1640 used for
the antibiotic disinfection of the 4°C and 37°C treatment groups was
2.5 +/- 0.21mM, coefficient of variation 8.4%. The average glutamine
concentration in RPM11640 used for the antibiotic disinfection of the 4°C + Gin
and 37°C + Gin was 10.36 +/- 0.81mM, coefficient of variation 7.81%

4.4 HEAT SHOCK PROTEIN 70 QUANTITATION - ANTIBIOTIC INCUBATION

A Hsp70 sandwich ELISA assay was performed to determine whether
incubation at 37°C or 37°C plus Gin during disinfection would result in increased
amounts of Hsp70 present in aortic conduit tissue cells over time.. The tissue
was incubated for 24 hours in antibiotics at the experimental temperatures, 4°C
and 37°C, with or without Gin as described in the Materials and Methods section.
The data were obtained by dividing the total picograms Hsp 70 by the total
milligrams of protein in the extract for each time point. Percent recovery analysis
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was performed as described in chapter 3.17 of the Materials and Methods. The
percent recovery of Hsp 70 was 94.5 +/-3.7%. The Hsp70 data set were
determined to be normally distributed.
Figure 6 demonstrates that there was not a statistically significant
difference in the amount of Hsp70 present in the cells of all the tissue treatment
groups at time zero, p > 0.05. There was not a statistically significant change in
the amount of Hsp 70 present in the tissue incubated at 4°C or 4°C + Gin over
the 24 hours of incubation, p > 0.05. There was statistically significantly more
Hsp70 present in the cells of the tissue incubated at 37°C with and without Gin
from the 1 hour assessment point through the conclusion of the 24 hour
incubation than in the cells of the tissue incubated at 4°C with and without Gin.
There was a statistically significant increase in the amount of Hsp70
present in the cells of the tissue incubated at 37°C between zero time and 1
hour, 1 hour and 2 hours and 2 hours and 6 hours, p < 0.05.
There was a statistically significant increase in the amount of Hsp70
present in the cells of the tissue incubated at 37°C + Gin between zero time and
1 hour, 1 hour and 2 hours and 3 hours and 4 hours. There was also a
statistically significant decrease in the amount of Hsp70 present between 4 hours
and 24 hours, p < 0.05. There was statistically significantly more Hsp70 present
in the cells of the tissue incubated at 37°C with Gin from the 1 hour assessment
point through the conclusion of the 24 hour incubation than in the cells of the
tissue incubated at 37°C without Gin.
These data demonstrate that incubation of aortic conduit tissue at 37°C
and 37°C plus Gin significantly increases the amount of Hsp 70 present in the
cells over a 24 hour period relative to their baseline Hsp 70 content and the 4°C
with and without Gin treatment groups. Additionally, 37°C plus Gin is superior to
37°C alone. These data also demonstrate that the largest increase in Hsp70
occurs between 3 and 4 hours of incubation at 37°C with Gin supplementation
and then declines over the remaining 24 hours but remains well above baseline.
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FIGURE 6. Quantitation of heat shock protein 70 in aortic conduit tissue
during disinfection under various treatment conditions. Treatment of human
aortic conduit at 37°C and at 37°C plus Gin, during antibiotic disinfection, the
results demonstrate increased amounts of and/or stability of Hsp 70 at 37°C with
and without Gin relative to treatment at 4°C prior to cryopreservation. Tissues
were incubated under their respective conditions, pulverized in liquid nitrogen,
detergent extracted, quantitated by Hsp 70 sandwich ELISA and results
normalized by Pierce BCA protein assay.
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4.5 HEAT SHOCK PROTEIN 70 QUANTITATION - INCUBATION
POST-CRYOPRESERVATION
To determine whether incubation at 37°C or 37°C plus Gin during the
antibiotic treatment phase would result in increased amounts of Hsp 70 present
in aortic conduit tissue that had been subsequently cryopreserved, thawed and
incubated at 37°C under 5% C02 for 72 hours, a Hsp70 sandwich ELISA assay
was performed. The tissue was incubated for 24 hours in antibiotics at the
experimental temperatures, 4°C and 37°C, with or without Gin, cryopreserved,
thawed and diluted of cryoprotectant and incubated in tissue culture media
optimized for the viability of vascular smooth muscle cells over 72 hours at 5%
CO2 as described in the Materials and Methods chapter. The data were obtained
by dividing the total picograms Hsp 70 by the total milligrams of protein in the
extract for each time point. Percent recovery analysis was performed as
described in chapter 3.17 (page 52) of the Materials and Methods. The percent
recovery of Hsp 70 was 94.5 +/-3.7%. The Hsp70 data set were determined to be
normally distributed.
Figure 7 demonstrates that the amount of Hsp70 detected at time zero
post-cryopreservation was not statistically different among any of the treatment
groups than the data obtained immediately pre-cryopreservation (24-hour time
point). In the tissue previously incubated at 4°C and 4°C + Gin there was no
statistically significant increase in Hsp70, p > 0.05. There was statistically
significantly more Hsp70 present in the cells of the tissue incubated at 37°C with
and without Gin from the 0 hour assessment point through the conclusion of the
72-hour incubation than in the cells of the tissue incubated at 4°C with and
without Gin.
There was not a statistically significant increase in the amount of Hsp70
present in the cells of the tissue incubated previously at 37°C without Gin after 72
hours in vitro, p> 0.05. However, there was a statistically significant decrease in
Hsp70 between 6 hours and 72 hours, p<0.05.
In the tissue previously incubated at 37°C plus Gin there was a statistically
significant increase in the amount of Hsp70 detected in the cells between 0 hours
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and 6 hours of incubation in vitro. Additionally, there was statistically significant
decline in Hsp70 present in the cells between 6 hours and 24 hours, 24 and 72
hours in vitro, p < 0.05. There was statistically significantly more Hsp70 present
in the cells of the tissue incubated at 37°C with Gin from the 0 hour assessment
point through the conclusion of the 72 hour incubation than in the cells of the
tissue incubated at 37°C without Gin.
These data demonstrate that incubation of aortic conduit tissue at 37°C
plus Gin significantly increases the amount of Hsp 70 present in the cells after
cryopreservation, thawing and incubation under tissue culture conditions over a
72-hour period relative to their baseline Hsp 70 content. The 4°C treatment
groups did respond to the heat shock of being placed at 37°C postcryopreservation by producing elevated amounts Hsp70 over baseline. The 37°C
with Gin group had greater Hsp70 content than the 4°C with and without Gin and
37°C without Gin treatment groups. These data also demonstrate that the
increase in Hsp70 occurs between 2 and 6 hours of incubation and then declines
over the remaining 24 hours but remains well above baseline. These data
demonstrate a difference in Hsp70 augmentation in cells relative to whether they
were supplemented with Gin. The unsupplemented group was able to maintain
elevated levels of Hsp70 while the supplemented group continued to augment
the amount of Hsp70 present over the first 6 hours in vitro.
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FIGURE 7. Quantitation of heat shock protein 70 in aortic conduit tissue
after cryopreservation. Treatment of human aortic conduit previously
incubated at 37°C and at 37°C plus Gin during antibiotic disinfection,
cryopreserved, thawed and incubated under cell culture conditions resulted in
increased amounts of and/or stability of Hsp 70 relative to treatment at 4°C post
cryopreservation. Tissues were incubated under their respective conditions,
pulverized in liquid nitrogen, detergent extracted, quantitated by Hsp 70
sandwich ELISA and results normalized by Pierce BCA protein assay.
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4.6 CYTOCHROME C QUANTITATION - CYTOSOLIC ANALYSIS DURING
ANTIBIOTIC INCUBATION

Cells entering or undergoing apoptosis can have increased amounts of
cytochrome c in their cytosol and therefore cytochrome c is a presumptive trigger
of the apoptotic cascade. To determine whether incubation at 37°C or 37°C plus
Gin would result in maintenance of baseline levels of cytochrome c in the cytosol
of aortic conduit tissue cells over time during antibiotic incubation, a cytochrome
c sandwich ELISA assay was performed. The tissue was incubated for 24 hours
in antibiotics at the experimental temperatures, 4°C and 37°C, with or without Gin
as described in the Materials and Methods chapter. The tissue samples were
digested and differentially centrifuged to separate the mitochondria from the
cytosol and nucleus. This methodology facilitated the detection of cytochrome c
in the cytosolic and mitochondrial fraction. The cytochrome c content of the
mitochondrial fraction can be found in chapter 4.8. The data were obtained by
dividing the total nanograms cytochrome c by the total milligrams of protein in the
extract for each time point. Percent recovery analysis was performed as
described in chapter 3.17 of the Materials and Methods. The percent recovery of
cytochrome c was 92.7 +/-5.7%. The cytochrome c, cytosolic data set were
determined to be normally distributed
Figure 8 demonstrates that in the tissue previously incubated at 4°C there
was a statistically significant increase in the amount of cytochrome c present in
the cytosol between 0 and 1 hour and 1 hour and 2 hours, p< 0.05. The amount
of cytochrome c in the cytosol was relatively constant thereafter. The tissue
incubated at 4°C plus Gin also had statistically significant increases in
cytochrome c content in the cytosol that replicated the same trend as the 4°C
samples. The increases in cytochrome c correspond to increases in capase-3
and TUNEL positive cells in chapters 4.12 and 4.14 respectively.
There was a statistically significant increase in the amount cytochrome c
present in the cytosol of cells incubated at 37°C between 1 and 4 hours, p< 0.05,
with a downward trend thereafter. In the tissue previously incubated at 37°C plus

64

Gin, there was not a statistically significant increase in the amount of cytochrome
c detected in the cytosol of the cells between zero and 24 hours of incubation in
antibiotics, p>0.05.
These data demonstrate that incubation at 4°C with or without Gin results
in an increase in cytosolic cytochrome c content. However, incubation of aortic
conduit tissue at 37°C plus Gin maintains the baseline level of cytochrome c
present in the cytosol. Treatment at 37°C without Gin results in a statistically
significant increase in cytochrome c content over baseline; however, not to the
degree noted in both 4°C treatment groups. Figures 9 and 10 clearly
demonstrate that there is an inverse relationship between the amount of Hsp70
present in the cell and the amount of cytochrome c that is found in the cytosol.
The less Hsp70 present in the cell, the more cytochrome c is found in the cytosol
(Figure 9) and conversely the more Hsp70 present in the cell, the less
cytochrome c is found in the cytosol (Figure 10). These data begin to establish a
relationship between elevated Hsp70 and an absence of pro-apoptotic conditions
in the cell.
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FIGURE 8. Quantitation of cytosolic cytochrome c in aortic conduit tissue
during disinfection under various treatment conditions. Treatment of human
aortic conduit at 37°C plus Gin, during antibiotic disinfection, results in
maintenance of baseline cytosolic cytochrome c levels relative to treatment at
4°C prior to cryopreservation. Tissues were incubated under their respective
conditions, pulverized in liquid nitrogen, detergent extracted, differentially
centrifuged to isolate the cytosolic cellular fraction, quantitated by cytochrome c
sandwich ELISA and results normalized by Pierce BCA protein assay.
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FIGURE 9. Cytosolic cytochrome c vs. Hsp70 content over time during
disinfection in the 4°C and 4°C+GLN treatment groups. These data
demonstrate the relationship between incubation at 4°C during disinfection, no
augmentation in Hsp70 and increasing amounts of cytochrome c detected in the
cytosol. The increase in cytosolic cytochrome c was similar with or without the
addition of GLN to the disinfection solution at 4°C. These data are derived from
the Hsp70 and cytochrome c ELISA results.
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FIGURE 10. Cytosolic cytochrome c vs. Hsp70 content over time during
disinfection in the 37°C and 37 °C+GLN treatment groups. These data
demonstrate the relationship between incubation at 37°C during disinfection,
increasing levels of Hsp70 and the amount of cytochrome c detected in the
cytosol. Comparing these data with those in Figure 9, the effect of increased
amounts Hsp70 on maintenance of intracellular cytochrome c levels is apparent.
These data are derived from the Hsp70 and cytochrome c ELISA results.
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4.7 CYTOCHROME C QUANTITATION - CYTOSOLIC ANALYSIS
POST-CRYOPRESERVATION

To determine whether incubation at 37°C or 37°C plus Gin during the
antibiotic treatment phase would result in increased amounts of cytochrome c
present in the cytosolic fraction of aortic conduit tissue that had been
subsequently cryopreserved, thawed and incubated at 37°C under 5% C02 for
72 hours, a cytochrome c sandwich ELISA assay was performed. The tissue
was incubated for 24 hours in antibiotics at the experimental temperatures, 4°C
and 37°C, with or without Gin, cryopreserved, thawed and diluted of
cryoprotectant and incubated in tissue culture media optimized for the viability of
vascular smooth muscle cells over 72 hours at 5% C02as described in the
Materials and Methods chapter. The data were obtained by dividing the total
nanograms of cytochrome c by the total milligrams of protein in the extract for
each time point. Percent recovery analysis was performed as described in
section 3.17 of the Materials and Methods chapter. The percent recovery of
cytochrome c was 92.7 +1-5.7%. The cytochrome c cytosolic data were
determined to be normally distributed.
Figure 11 demonstrates that there was not a statistically significant
difference in the amount of cytochrome c detected immediately prior to
cryopreservation and the zero time point in the current series for any of the
treatment groups. In the tissue previously incubated at 4°C and 4°C plus Gin, the
amount of cytochrome c present in the cytosol during the incubation did not
increase; however, there was a statistically significant decline between 6 and 24
hours, p< 0.05. This trend continued for the remaining incubation period.
There was a statistically significantly increase in the amount cytochrome c
present in the cytosol of cells in the tissue previously incubated at 37°C, after 6
hours in vitro, p< 0.05. In the tissue previously incubated at 37°C plus Gin there
was not a statistically significant increase in the amount of cytochrome c detected
in the cytosol of the cells between zero and 72 hours of incubation in tissue
culture media, p>0.05; however, there was decrease over time. The increases in
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cytochrome c correspond to increases in capase-3 and TUNEL positive cells in
chapters 4.13 and 4.15 respectively.
These data demonstrate that incubation of aortic conduit tissue at 37°C
plus Gin maintains the baseline level of cytochrome c present in the cytosol and
that Gin is necessary to achieve the result. However, incubation at 4°C with or
without Gin results in elevated levels of cytochrome c in the cytosol that decline
over time potentially due to degradation. Figures 12 and 13 clearly demonstrate
that there continues to be an inverse relationship between the amount of Hsp70
present in the cell and the amount of cytochrome c that is found in the cytosol.
The less Hsp70 present in the cell, the more cytochrome c is found in the cytosol
(Figure 12) and conversely the more Hsp70 present in the cell, the less
cytochrome c is found in the cytosol (Figure 13). The data obtained during the
disinfection/treatment phase of the experimentation mirror the data obtained
during the in vitro portion of the study. These data continue to establish a
relationship between elevated Hsp70 and an absence of pro-apoptotic conditions
in the cell.
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FIGURE 11. Quantitation of cytosolic cytochrome c in aortic conduit tissue
after cryopreservation. Treatment of human aortic conduit previously
incubated at 37°C plus Gin during antibiotic disinfection, cryopreserved, thawed
and incubated under cell culture conditions results in declining amounts of
cytochrome c post cryopreservation relative to treatment at 4°C prior to
cryopreservation. Tissues were incubated under their respective conditions,
pulverized in liquid nitrogen, detergent extracted, differentially centrifuged to
isolate the cytosolic cellular fraction, quantitated by cytochrome c sandwich
ELISA and results normalized by Pierce BCA protein assay.

71

2000
4C CYTOCHROME C
4C +GLN CYTOCHROME C
4C HSP70
4C + GLN HSP 70

1200 £

6

24

TIME (HOURS)

FIGURE 12. Cytosolic cytochrome c vs. Hsp70 content over time postcryopreservation in the 4°C and 4°C+GLN treatment groups. These data
demonstrate the relationship between incubation at 4°C during disinfection, no
augmentation in Hsp70 and elevated amounts of cytochrome c detected in the
cytosol. These data are derived from the Hsp70 and cytochrome c ELISA results.
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FIGURE 13. Cytosolic cytochrome c vs. Hsp70 content over time postcryopreservation in the 37°C and 37 °C+GLN treatment groups. These data
demonstrate the relationship between incubation at 37°C with Gin during
disinfection, increasing levels of Hsp70 and the amount of cytochrome c detected
in the cytosol. Comparing these data with those in Figure 12, the effect of
increased amounts Hsp70 on maintenance of low cytoplasmic cytochrome c
levels is apparent. These data are derived from the Hsp70 and cytochrome c
ELISA results.
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4.8 CYTOCHROME C QUANTITATION - MITOCHONDRIAL ANALYSIS
DURING ANTIBIOTIC INCUBATION

Cells entering or undergoing apoptosis can have increased amounts of
cytochrome c in their cytosol and therefore it is a presumptive trigger of the
apoptotic cascade. To determine whether incubation at 37°C or 37°C plus Gin
would result in maintenance of baseline levels of cytochrome c in the
mitochondria of aortic conduit tissue cells over time during antibiotic incubation, a
cytochrome c sandwich ELISA assay was performed. The tissue was incubated
for 24 hours in antibiotics at the experimental temperatures, 4°C and 37°C, with
or without Gin as described in the Materials and Methods chapter. The data were
obtained by dividing the total nanograms cytochrome c by the total milligrams of
protein in the extract for each time point. Percent recovery analysis was
performed as described in chapter 3.17 of the Materials and Methods chapter.
The percent recovery of cytochrome c was 92.7 +/-5.7%. The mitochondrial
cytochrome c data were determined to be normally distributed
Figure 14 demonstrates that there was not a statistically significant
difference in the amount of cytochrome c present in the mitochondria of the cells
in all the tissue treatment groups at time zero, p > 0.05. The cells in the tissues
incubated at 4°C with and with out Gin experienced a significant decrease in the
amount of cytochrome c present in the mitochondria between zero time and three
hours of incubation, p < 05. The decreases in cytochrome c correspond to
increases in capase-3 and TUNEL positive cells in chapters 4.12 and 4.14
respectively.
In the tissue previously incubated at 37°C there was a statistically
significant decrease in the amount of cytochrome c detected in the mitochondria
of the cells between zero and 3 hours of incubation in antibiotics, p<0.05. In the
tissue previously incubated at 37°C plus Gin there was not a statistically
significant decrease in the amount of cytochrome c detected in the mitochondria
of the cells between zero and 24 hours of incubation in antibiotics, p>0.05. The
tissues previously incubated at 37°C with and without Gin contained statistically
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significantly more cytochrome c in their mitochondria for the duration of the
incubation relative to both 4°C treatment groups.
These data demonstrate that incubation of aortic conduit tissue at 37°C
plus Gin maintains the baseline level of cytochrome c present in the
mitochondria. Incubation at 37°C alone results in a significant decrease in
mitochondrial cytochrome c but not nearly as dramatic as the decrease in the
4°C and 4°C with Gin treatment groups. Figures 15 and 16 clearly demonstrate
that there is a relationship between the amount of Hsp70 present in the cell and
the amount of cytochrome c that is found in the mitochondria. A lack of increased
Hsp70 correlates with declining amounts of cytochrome c in the mitochondria
over time when the tissue is not heat shocked (Figure 15). Conversely,
augmentation of the Hsp70 levels corresponds with maintenance of
mitochondrial cytochrome c levels (Figure 16). Additionally, it is apparent heat
shock in the absence of Gin is not as successful at maintaining the cytochrome c
in the mitochondria. These results correlate with those in Figures 8-10 that
demonstrated during the disinfection/treatment phase of this study a lack of
Hsp70 correlated with high levels of cytoplasmic cytochrome c.
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FIGURE 14. Quantitation of mitochondrial cytochrome c in aortic conduit
tissue during disinfection under various treatment conditions. Treatment of
human aortic conduit at 37°C plus Gin, during antibiotic disinfection, results in
maintenance of baseline mitochondrial cytochrome c levels relative to treatment
at 4°C prior to cryopreservation. Tissues were incubated under their respective
conditions, pulverized in liquid nitrogen, detergent extracted, differentially
centrifuged to isolate the mitochondrial fraction, quantitated by cytochrome c
sandwich ELISA and results normalized by Pierce BCA protein assay.
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FIGURE 15. Mitochondrial cytochrome c vs. Hsp70 content over time
during disinfection in the 4°C and 4°C+GLN treatment groups. These data
demonstrate the relationship between incubation at 4°C during disinfection, lack
of augmentation in Hsp70 levels and decreasing amounts of cytochrome c
detected in the mitochondria. The decrease in mitochondrial cytochrome c was
similar with or without the addition of Gin to the 4°C disinfection solution. The
decrease in mitochondrial cytochrome c also corresponds with the increase in
cytosolic cytochrome c demonstrated in Figure 8. These data are derived from
the Hsp70 and cytochrome c ELISA results.
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FIGURE 16. Mitochondrial cytochrome c vs. Hsp70 content over time
during disinfection in the 37°C and 37°C+GLN treatment groups. These data
demonstrate the relationship between incubation at 37°C during disinfection,
increased levels of Hsp70 and the amount of cytochrome c detected in the
mitochondria. The increased amounts of Hsp70 and steady state of mitochondrial
cytochrome c demonstrate the benefit of incubating at 37°C in the presence of
Gin. The elevated steady state in mitochondrial cytochrome c levels corresponds
with the steady, low state of cytochrome c in the cytosol as demonstrated in
Figure 8.
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4.9 CYTOCHROME C QUANTITATION - MITOCHONDRIAL ANALYSIS
POST-CRYOPRESERVATION

To determine whether incubation at 37°C or 37°C plus Gin during the
antibiotic treatment phase would result in maintenance in the amounts of
cytochrome c present in the mitochondrial fraction of aortic conduit tissue that
had been subsequently cryopreserved, thawed and incubated at 37°C under 5%
C02 for 72 hours, a cytochrome c sandwich ELISA assay was performed. The
tissue was incubated for 24 hours in antibiotics at the experimental temperatures,
4°C and 37°C, with or without Gin, cryopreserved, thawed and diluted of
cryoprotectant and incubated in tissue culture media optimized for the viability of
vascular smooth muscle cells over 72 hours at 5% C02as described in the
Materials and Methods chapter. The data were obtained by dividing the total
nanograms of cytochrome c by the total milligrams of protein in the extract for
each time point. Percent recovery analysis was performed as described in
chapter 3.17 of the Materials and Methods chapter. The percent recovery of
Hsp70 was 92.7 +/-5.7%. The mitochondrial cytochrome c data set were
determined to be normally distributed.
Figure 17 demonstrates that the 4°C and 4°C plus Gin did not experience
a statistically significant change in the amount of mitochondrial cytochrome c,
p>0.05 during the 72 hour incubation. In the tissue previously incubated at 37°C
and 37°C plus Gin there was not a statistically significant change in the amount
of cytochrome c detected in the mitochondria of the cells between zero and 72
hours of incubation in tissue culture media, p>0.05. However, the cells in the
tissue previously incubated at 37°C with Gin had statistically significantly more
mitochondrial cytochrome c than the tissue incubated at 37°C without Gin,
p<0.05. The increases in cytochrome c correspond to increases in capase-3 and
TUNEL positive cells in chapters 4.13 and 4.15 respectively.
Figures 18 and 19 clearly demonstrate that there is a relationship between
the amount of Hsp70 present in the cell and the amount of cytochrome c that is
found in the mitochondria during the in vitro incubation. A lack of increased
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Hsp70 correlates with sustained low quantities of cytochrome c in the
mitochondria overtime (Figure 18). Conversely, augmentation of the Hsp70
levels corresponds with maintenance of mitochondrial cytochrome c levels
(Figure 19). Additionally, it is apparent heat shock in the absence of Gin is not as
successful over the time course studied. These results correlate with those in
Figures 11-13, that demonstrated during the in vitro incubation phase of this
study a lack of Hsp70 correlated with high levels of cytoplasmic cytochrome c
and high levels of Hsp70 correlated with low levels of cytoplasmic cytochrome c.
Figure 20 summarizes the amount of cytochrome c present in the mitochondria
over both phases of the study. This figure clearly demonstrates a decline in
mitochondrial cytochrome c over time for the 4°C treatment groups, even with
Gin supplementation and being placed at 37°C post-cryopreservation, i.e. being
heat shocked. Conversely, 37°C with Gin maintained a steady state of
mitochondrial cytochrome c for the duration of the study.
These data demonstrate that incubation of aortic conduit tissue at 37°C
plus Gin maintains the baseline level of cytochrome c present in the mitochondria
after cryopreservation, thaw and dilution and additional incubation at 37°C. The
37°C without Gin group experienced a significant decrease in mitochondrial
cytochrome c content over time and was unable to return to baseline during the
in vitro incubation (heat shock). The 4°C and 4°C plus Gin groups sustained
continuously low amounts of mitochondrial cytochrome c and these levels are
significantly lower than those for the 37°C with or without Gin treatment groups.
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FIGURE 17. Quantitation of mitochondrial cytochrome c in aortic conduit
tissue after cryopreservation. Treatment of human aortic conduit previously
incubated at 37°C plus Gin during antibiotic disinfection, cryopreserved, thawed
and incubated under cell culture conditions maintains the amount of cytochrome
c post cryopreservation in the mitochondria relative to treatment at 4°C prior to
cryopreservation. Tissues were incubated under their respective conditions,
pulverized in liquid nitrogen, detergent extracted, differentially centrifuged to
isolate the mitochondrial fraction, quantitated by cytochrome c sandwich ELISA
and results normalized by Pierce BCA protein assay.
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FIGURE 18. Mitochondrial cytochrome c vs. Hsp70 content over time postcryopreservation in the 4°C and 4°C+GLN treatment groups. These data
demonstrate the relationship between incubation at 4°C during disinfection,
maintenance of baseline levels of Hsp70 and no increase in the amounts of
cytochrome c detected in the mitochondria during the post-cryopreservation
incubation at 37°C. These data demonstrate that the addition Gin during
disinfection at 4°C makes no difference in the amount of Hsp70 present in the
cells. These data are derived from the Hsp70 and cytochrome c ELISA results.

82

2000
37C CYTOCHROME C
37C + GLN CYTOCHROME C

1800

37C HSP 70
37C + GLN HSP70

1600
1400

1200 I
o
£

o

1000 g
&.
V)
X

800
600

400

200

6

24

TIME (HOURS)

FIGURE 19. Mitochondrial cytochrome c vs. Hsp70 content in the cells
post-cryopreservation in the 37°C and 37°C+GLN treatment groups. These
data demonstrate the relationship between incubation at 37°C during disinfection,
increased levels of Hsp70 and maintenance in the amounts of cytochrome c
detected in the mitochondria during the post-cryopreservation incubation at 37°C.
The group incubated during disinfection with Gin has increased levels of Hsp70
and mitochondrial cytochrome c relative to the tissues without added Gin. These
data demonstrate that the addition Gin during disinfection makes a difference in
the amount of Hsp70 present in the cells and mitochondrial cytochrome c. These
data are derived from the Hsp70 and cytochrome c ELISA results.
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FIGURE 20. Cytochrome c content in the mitochondria for each treatment
group for the duration of the study - disinfection and postcryopreservation. These data demonstrate that the tissues incubated at 4°C
during disinfection had a severe drop in mitochondrial cytochrome c that was
never recovered. Tissues incubated at 37°C during disinfection experienced
declining levels of cytochrome c; however, after one hour post-cryopreservation
the mitochondrial cytochrome c levels approach a steady state. The tissue
incubated at 37°C in the presence of glutamine demonstrate mildly fluctuating
levels of cytochrome c, but over the course of the study the amount of
mitochondrial cytochrome c was consistent. Increased levels of cytosolic
cytochrome c are known activators of Apaf-1 and thus the apoptotic cascade.
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4.10 BCL-2 QUANTITATION - PRECRYOPRESERVATION

Cells resisting entering or undergoing apoptosis can have increased
amounts of Bcl-2 and therefore an increase in Bcl-2 over baseline may be
indicative of a cellular population resisting entering the apoptotic cascade. To
determine whether incubation at 37°C or 37°C plus Gin would result in increased
levels of Bcl-2 in aortic conduit tissue cells over time during antibiotic incubation,
a Bcl-2 sandwich ELISA assay was performed. The tissue was incubated for 24
hours in antibiotics at the experimental temperatures, 4°C and 37°C, with or
without Gin as described in the Materials and Methods chapter. The data were
obtained by dividing the total units of Bcl-2 by the total milligrams of protein in the
extract for each time point. Percent recovery analysis was performed as
described in chapter 3.17 of the Materials and Methods. The percent recovery of
Bcl-2 was 91.3 +/-4.9%. The Bcl-2 data set were determined to be normally
distributed
Figure 21 demonstrates that there was not a statistically significant
difference in the amount of Bcl-2 present in the cells in all the tissue treatment
groups at time zero, p > 0.05. There was no change in the amount of Bcl-2
detected in the 4°C and 4°C plus Gin treatment groups, p > 0.05. There was an
increase in Bcl-2 in the 37°C group during the incubation but it was not
significant. There was a statistically significant increase in Bcl-2 content in the
37°C plus Gin group between 2 and 4 hours, p < 0.05, and it continued to
increase and plateau between 6 and 24 hours of incubation. Figures 22 and 23
demonstrate an absence of increased Bcl-2 in the 4°C treatment groups
correlates with no increase in Hsp70 and an increase in Bcl-2 correlates well with
an increase in Hsp70 as demonstrated by both 37°C treatment groups.
These data demonstrate that at 37°C and most significantly in the
presence of Gin there is an increase in Bcl-2 which correlates with an increase in
Hsp70 over time.
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FIGURE 21. Quantitation of Bcl-2 in aortic conduit tissue during
disinfection under various treatment conditions. Treatment of human aortic
conduit at 37°C plus Gin, during antibiotic disinfection, results in an increase in
Bcl-2 levels, relative to treatment at 4°C prior to cryopreservation. Tissues were
incubated under their respective conditions, pulverized in liquid nitrogen,
detergent extracted, quantitated by cytochrome c sandwich ELISA and results
normalized by Pierce BCA protein assay.
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FIGURE 22. Bcl-2 vs. Hsp70 content over time during disinfection in the 4°C
and 4°C+GLN treatment groups. These data demonstrate the relationship
between incubation at 4°C during disinfection and maintenance of baseline levels
of Hsp70 and Bcl-2. Increased levels of Bcl-2 are known to be anti-apoptotic by
preventing cytochrome c from exiting the mitochondria and as such these data
support the decrease in mitochondrial cytochrome c demonstrated in Figure 14.
These data are derived from the Hsp70 and Bcl-2 ELISA results.
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FIGURE 23. Bcl-2 vs. Hsp70 content over time during disinfection in the
37°C and 37°C+GLN treatment groups. These data demonstrate the
relationship between incubation at 37°C plus Gin during disinfection, increased
levels of Hsp70 and increased levels of Bcl-2. The increased amounts of Hsp70
and Bcl-2 in the 37°C plus Gin treatment group demonstrate the benefit of
incubating at 37°C in the presence of Gin. Increased levels of Bcl-2 are known to
be anti-apoptotic by preventing cytochrome c from exiting the mitochondria and
as such these data support the maintenance in mitochondrial cytochrome c in the
37°C plus Gin treatment group demonstrated in Figure 14. These data are
derived from the Hsp70 and Bcl-2 ELISA results.
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4.11 BCL-2 QUANTITATION - POSTCRYOPRESERVATION

To determine whether incubation at 37°C or 37°C plus Gin during the
antibiotic treatment phase would result in increased amounts of Bcl-2 in aortic
conduit tissue that had been subsequently cryopreserved, thawed and incubated
at 37°C under 5% CO2 for 72 hours, a Bcl-2 sandwich ELISA assay was
performed. The tissue was incubated for 24 hours in antibiotics at the
experimental temperatures, 4°C and 37°C, with or without Gin, cryopreserved,
thawed and diluted of cryoprotectant and incubated in tissue culture media
optimized for the viability of vascular smooth muscle cells over 72 hours at 5%
CO2 as described in the Materials and Methods chapter. The data were obtained

by dividing the total units of Bcl-2 by the total milligrams of protein in the extract
for each time point. Percent recovery analysis was performed as described in
chapter 3.17 of the Materials and Methods chapter. The percent recovery of Bcl2 was 91.3 +/-4.9%. The Bcl-2 data set were determined to be normally
distributed
Figure 24 demonstrates that there was not a statistically significant
change in the amount of Bcl-2 present in the 4°C, 4 °C plus Gin and 37°C
treatment groups, p>0.05. There was a statistically significant increase in Bcl-2 in
the 37°C plus Gin group between 2 and 6 hours, p<0.05, and a statistically
significant decline between 6 and 26 hours, 24 and 48 hours and 48 and 72
hours, p < 0.05. Figure 25 demonstrates that an absence of increased Hsp70
correlates with an absence of increased Bcl-2 over baseline for both 4°C
treatment groups. Figure 26 demonstrates than an increase in Hsp70 correlates
with an increase in Bcl-2 for both 37°C treatment groups; however, the 37°C plus
Gin group experiences the largest increases in Bcl-2.
These data demonstrate that the 37°C treatment group supplemented with
Gin during the antibiotic incubation experienced an increase in the anti-apoptotic
Bcl-2 protein that correlated positively with increases in Hsp70.
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FIGURE 24. Quantitation of Bcl-2 in aortic conduit tissue after
cryopreservation. Treatment of human aortic conduit previously incubated at
37°C plus Gin during antibiotic disinfection, cryopreserved, thawed and incubated
under cell culture conditions results in increased amounts of Bcl-2 after 6 hours
of incubation, post cryopreservation relative to treatment at 4°C prior to
cryopreservation. Tissues were incubated under their respective conditions,
pulverized in liquid nitrogen, detergent extracted, quantitated by cytochrome c
sandwich ELISA and results normalized by Pierce BCA protein assay.
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FIGURE 25. Bcl-2 vs. Hsp70 content over time post-cryopreservation in the
4°C and 4°C+GLN treatment groups. These data demonstrate the relationship
between incubation at 4°C during disinfection, maintenance of baseline levels of
Hsp70 and no increase in the amounts of Bcl-2 detected in the cells during the
post-cryopreservation incubation at 37°C. These data demonstrate that the
addition Gin during disinfection at 4°C makes no difference in the amount of
Hsp70 present in the cells. Increased levels of Bcl-2 are known to be antiapoptotic by preventing cytochrome c from exiting the mitochondria and as such
these data support the decrease in mitochondrial cytochrome c demonstrated in
Figure 14. These data are derived from the Hsp70 and Bcl-2 ELISA results.
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FIGURE 26. Bcl-2 vs. Hsp70 content in the cells post-cryopreservation in
the 37°C and 37°C+GLN treatment groups. These data demonstrate the
relationship between incubation at 37°C plus Gin during disinfection, increased
levels of Hsp70 and increased levels of Bcl-2 during the post-cryopreservation
incubation at 37°C. These data demonstrate that the addition Gin during
disinfection makes a difference in the amount of Hsp70 and Bcl-2 present in the
cells. Increased levels of Bcl-2 are known to be anti-apoptotic by preventing
cytochrome c from exiting the mitochondria and as such, these data support the
maintenance in mitochondrial cytochrome c levels demonstrated in Figure 14.
These data are derived from the Hsp70 and Bcl-2 ELISA results.

92

4.12 CASPASE-3 IMMUNOHISTOCHEMISTRY - PRECRYOPRESERVATION

The presence of caspase-3 indicates a cell is committed to completion of
the apoptotic cascade. Therefore to determine whether incubation at 37°C or
37°C plus Gin would result in maintenance of baseline levels of caspase-3, it was
probed for using immunohistochemistry and quantitated histomorphometrically.
The tissue was incubated for 24 hours in antibiotics at the experimental
temperatures, 4°C and 37°C, with or without Gin as described in the Materials
and Methods chapter. The data were obtained by dividing the total number of
caspase-3 positive cells in the tissue section by the total number of cells present
in the tissue sections on the companion Hematoxylin and Eosin stained slides
and the percentage of positive cells was obtained. The caspase-3 data set were
determined to be normally distributed.
Figure 27 demonstrates that at time zero there was not a statistically
significant difference in the number of caspase-3 positive cells, p>0.05. The 4°C,
4°C plus Gin and 37°C treatment groups experienced a significant increase in
caspase-3 positive cells over baseline p<0.05; however, the number of caspase3 positive cells in the 37°C treatment group was significantly lower than both 4°C
treatment groups, p< 0.05. The 37°C plus Gin group did not experience a
statistically significant increase in the percentage of caspase-3 positive cells over
baseline, p> 0.05. Figure 28 demonstrates that without an increase in Hsp70
there is a significant increase in the number caspase-3 positive cells both 4°C
treatment groups. Conversely, Figure 29 demonstrates that with an increase in
Hsp70 there is not a significant increase the number caspase-3 positive cells in
the 37°C plus Gin treatment group. Representative micrographs of caspase-3
immunostained tissue sections are provided in Figures 33-40.
These data demonstrate that cells incubated at 37°C with Gin do not
experience an increase in caspase-3 positive cells, relative to the other three
treatment modalities. Increased amounts of Hsp70 correlate with a lack of
increased amounts of caspase-3 positive cells.
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FIGURE 27. Quantitation of caspase-3 in aortic conduit tissue during
disinfection under various treatment conditions. Treatment of human aortic
conduit at 37°C plus Gin, during antibiotic disinfection, results in no significant
increase in caspase-3 positive cells over time, relative to treatment at 4°C prior to
cryopreservation. Tissues were incubated under their respective conditions,
formalin fixed, paraffin embedded, sectioned and probed with an antibody
specific for the active form of caspase-3 using standard immunohistochemical
procedures.
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FIGURE 28. Caspase-3 vs. Hsp70 content in the cells during disinfection in
the 4°C and 4°C+GLN treatment groups. These data demonstrate the
relationship between incubation at 4°C during disinfection, maintenance of
baseline levels of Hsp70 and decreasing amounts of caspase-3 detected in the
cell. The increased levels of caspase-3 correspond with the increased levels of
cytochrome c in the cytosol and baseline levels of Bcl-2, Figures 8 and 21
respectively, as all of these biomarkers are predecessors to initiation of the
apoptotic cascade. These data are derived from the Hsp70 ELISA and caspase3 immunohistochemistry results.
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FIGURE 29. Percentage of Caspase-3 positive cells vs. Hsp70 content over
time during disinfection in the 37°C and 37°C+GLN treatment groups. These
data demonstrate the relationship between incubation at 37°C during disinfection,
increased levels of Hsp70 and the amount of caspase-3 detected in the cells.
The increased amounts of Hsp70 and steady state of caspase-3 demonstrate the
benefit of incubating at 37°C in the presence of Gin. The increased levels of
caspase-3 in the 37°C treatment group corresponds with the increased levels of
cytochrome c and small increase in Bcl-2, Figures 8 and 21 respectively, as all of
these biomarkers are predecessors to initiation of the apoptotic cascade.
Conversely, the baseline levels of caspase-3 in the 37°C plus Gin treatment
group, the baseline levels of cytoplasmic cytochrome c and the increased levels
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of Bcl-2 reflect the protective effects of elevated levels of Hsp70. These data are
derived from the Hsp70 ELISA and caspase-3 immunohistochemistry results.

4.13 CASPASE-3 IMMUNOHISTOCHEMISTRYPOST-CRYOPRESERVATION

To determine whether incubation at 37°C or 37°C plus Gin during the
antibiotic treatment phase would result in maintenance of baseline levels of
caspase-3 positive cells in aortic conduit tissue that had been subsequently
cryopreserved, thawed and incubated at 37°C under 5% CO2 for 72 hours,
immunohistochemistry and histomorphometry were used to detect and quantitate
caspase-3. The tissue was incubated for 24 hours in antibiotics at the
experimental temperatures, 4°C and 37°C, with or without Gin, cryopreserved,
thawed and diluted of cryoprotectant and incubated in tissue culture media
optimized for the viability of vascular smooth muscle cells over 72 hours at 5%
C02 as described in the Materials and Methods chapter. The data were obtained
by dividing the total number of caspase-3 positive cells in the tissue section by
the total number of cells present in the tissue sections on the companion slides
and obtaining the percentage of positive cells. The caspase-3 data set were
normally distributed.
Figure 30 demonstrates that the 4°C and 4°C plus Gin treatment groups
experienced a significant increase in caspase-3 positive cells over baseline,
p<0.05, specifically between 2 and 24 hours, p<0.05. The 37°C treatment group
also experienced a significant increase in caspase-3 positive cells between 2 and
6 hours; however, the number of caspase-3 positive cells in the 37°C treatment
group was significantly lower than both 4°C treatment groups, p< 0.05. The 37°C
plus Gin group did not experience a statistically significant increase in the
percentage of caspase-3 positive cells over baseline, p> 0.05. Figure 31
demonstrates that without an increase in Hsp70 there is a significant increase the
number caspase-3 positive cells in both 4°C treatment groups. Conversely,

97

Figure 32 demonstrates that with an increase in Hsp70 there is not a significant
increase the number caspase-3 positive cells in the 37°C plus Gin treatment
group. Representative micrographs of caspase-3 immunostained tissue sections
are provided in Figures 33-40.
These data demonstrate that cells in tissue incubated at 37°C with Gin do
not experience an increase in caspase-3 positive cells, relative to the other three
treatment modalities that do experience an increase in caspase-3 positive cells.
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FIGURE 30. Quantitation of caspase-3 in aortic conduit tissue after
cryopreservation. Treatment of human aortic conduit previously incubated at
37°C plus Gin during antibiotic disinfection, cryopreserved, thawed and incubated
under cell culture conditions results in no significant increase in caspase-3
positive cells over time, post cryopreservation relative to treatment at 4°C prior to
cryopreservation. Tissues were incubated under their respective conditions,
formalin fixed and probed with an antibody specific for the active form of
caspase-3 using standard immunohistochemical procedures.
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FIGURE 31. Percentage of Caspase-3 positive cells vs. Hsp70 content in the
cells post-cryopreservation in the 4°C and 4°C+GLN treatment groups.
These data demonstrate the relationship between incubation at 4°C during
disinfection, maintenance of baseline levels of Hsp70 and increased amounts of
caspase-3 detected during the post-cryopreservation incubation at 37°C. These
data demonstrate that the addition Gin during disinfection makes no difference in
the amount of Hsp70 present in the cells. The increased levels of caspase-3
correspond with the increased levels of cytochrome c in the cytosol and baseline
levels of Bcl-2, Figures 11 and 24 respectively, as all of these biomarkers are
predecessors to initiation of the apoptotic cascade. These data are derived from
the Hsp70 ELISA and caspase-3 immunohistochemistry results.
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FIGURE 32. Percentage of caspase-3 positive cells vs. Hsp70 content over
time post-cryopreservation in the 37°C and 37°C+GLN treatment groups.
These data demonstrate the relationship between incubation at 37°C plus Gin
during disinfection, increased levels of Hsp70 and maintenance of the baseline
percentage of caspase-3 positive cells detected during the post-cryopreservation
incubation at 37°C. The baseline level of caspase-3 in the 37°C plus Gin
treatment group correspond with the baseline levels of cytochrome c in the
cytosol and increased levels of Bcl-2, Figures 11 and 24 respectively. These
levels of the apoptotic biomarkers in 37°C plus Gin treatment group are indicative
of a cell population that should not succumb to apoptosis beyond that associated
with normal cellular turn-over. The same cannot be said for the 37°C treatment
group. These data are derived from the Hsp70 ELISA and caspase-3
immunohistochemistry results.
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FIGURE 33. Caspase-3 Positive Control. Micrograph demonstrating blue
nuclear staining and brick-red staining of caspase-3 in the cytoplasm, 100X.
Areas containing numerous positive cells are indicated by the arrows. Fifteen
percent of the cells in this control are positive.
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FIGURE 34. Caspase-3 Positive Control. Micrograph demonstrating blue
nuclear staining and brick-red staining of caspase-3 in the cytoplasm, 200X.
Areas containing numerous positive cells are indicated by the arrows.
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FIGURE 35. Caspase-3 Negative Control. Micrograph demonstrating blue
nuclear staining and absent brick-red staining for caspase-3 in the cytoplasm,
200X. The negative control was generated from the same tissue as in Figure 34;
however, the primary antibody was omitted during the staining procedure.
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FIGURE 36. Baseline caspase-3 staining. This micrograph is of a tissue
section from the 37°C + Gin experimental group at 0 time post thaw to
demonstrate a sample where thresholding revealed that approximately 5% of the
cells were caspase-3 positive, 100X. The nuclei stain blue and caspase-3
positive cells stain brick red in the cytoplasm. The arrows are pointing to the
areas, which stained positively for caspase-3.
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FIGURE 37. Baseline caspase-3 staining. This micrograph is of a tissue
section from the 37°C + Gin experimental group at 0 time post thaw to
demonstrate a sample where thresholding revealed that approximately 5% of the
cells were caspase-3 positive, 200X. The nuclei stain blue and caspase-3
positive cells stain brick red in the cytoplasm. The arrows are pointing to the
areas, which stained positively for caspase-3.
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FIGURE 38. Caspase-3 micrograph, 25% positivity. This micrograph is of a
tissue section from the 4°C plus Gin experimental group at 6 hours post-thaw to
demonstrate a sample where thresholding revealed that approximately 25% of
the cells were caspase-3 positive, 100X. The nuclei stain blue and caspase-3
positive cells stain brick red in the cytoplasm. The arrows are pointing to the
areas, which stained positively for caspase-3.
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FIGURE 39. Caspase-3 micrograph, 25% positivity. This micrograph is of a
tissue section from the 4°C plus Gin experimental group at 6-hours post-thaw to
demonstrate a sample where thresholding revealed that approximately 25% of
the cells were caspase-3 positive, 200X. The nuclei stain blue and caspase-3
positive cells stain brick red in the cytoplasm. The arrows are pointing to the
areas, which stained positively for caspase-3.
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FIGURE 40. Caspase-3 micrograph, 45% positivity. This micrograph is of a
tissue section from the 4°C experimental group at 48-hours post-thaw to
demonstrate a sample where thresholding revealed that approximately 45% of
the cells were caspase-3 positive, 100X. The nuclei stain blue and caspase-3
positive cells stain brick red in the cytoplasm. The arrows are pointing to the
areas, which stained positively for caspase-3.
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4.14 VISUALIZATION OF APOPTOTIC CELLS - PRECRYOPRESERVATION

The presence of TUNEL positive cells indicates the cell has initiated the
classical cellular apoptotic changes that are discernable under the microscope.
To determine whether incubation at 37°C or 37°C plus Gin would result in
maintenance of baseline levels of apoptotic in aortic conduit tissue cells over time
during antibiotic incubation, apoptotic cells were detected using the TUNEL
assay and histomorphometrically quantitated. The tissue was incubated for 24
hours in antibiotics at the experimental temperatures, 4°C and 37°C, with or
without Gin as described in the Materials and Methods chapter. The data were
obtained by dividing the total number of TUNEL positive cells in the tissue
section by the total number of cells present in the tissue sections on the
companion Hematoxylin and Eosin slides and obtaining the percentage of
positive cells. The TUNEL data are normally distributed
Figure 41, demonstrates that at time zero there was not a statistically
significant difference in the number of TUNEL positive cells, p>0.05. The 4°C and
4°C plus Gin treatment groups experienced a significant increase in TUNEL
positive cells over baseline, p<0.05, specifically between 6 and 24 hours, p<0.05.
The 37°C treatment group had significantly less TUNEL positive cells than both
4°C treatment groups after 6 and 24-hours of incubation, p< 0.05. However, the
24-hour 37°C samples had significantly more apoptotic cells over baseline
relative to the 37°C plus Gin treatment group. The 37°C plus Gin group did not
experience a statistically significant increase in the percentage of TUNEL positive
cells over baseline, p> 0.05. Figure 42 demonstrates that incubation at 4°C,
regardless of Gin supplementation, results in increased numbers of TUNEL
positive cells and correlates with a lack of Hsp70 production. Figure 43
demonstrates that incubation at 37°C, especially in the presence of Gin results in
no significant increase in the number of TUNEL positive cells and correlates with
elevated Hsp70 levels. Without Gin supplementation, there is an increase in
TUNEL positive cells in the 37°C group in spite of an increase in Hsp70.

110

Representative micrographs of TUNEL stained tissue sections are provided in
Figures 47-51.
These data demonstrate that cells incubated at 37°C with Gin do not
experience an increase in TUNEL positive cells, relative to the other three
treatment modalities that do experience an increase in TUNEL positive cells.
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FIGURE 41. Quantitation of TUNEL positive cells in aortic conduit tissue
during disinfection under various treatment conditions. Treatment of human
aortic conduit at 37°C plus Gin, during antibiotic disinfection, results in no
significant increase in TUNEL positive cells over time, relative to treatment at 4°C
prior to cryopreservation. Tissues were incubated under their respective
conditions, formalin fixed; paraffin embedded, sectioned and investigated using
the TUNEL assay. Positive control slides were 42% positive.
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FIGURE 42. Percentage of TUNEL positive cells vs. Hsp70 content over
time during disinfection in the 4°C and 4°C+GLN treatment groups. These
data demonstrate the relationship between incubation at 4°C during disinfection,
maintenance of baseline levels of Hsp70 and increasing percentage of TUNEL
positive cells detected in the tissue. The increase in percentage of TUNEL
positive cells was similar with or without the addition of Gin to the 4°C disinfection
solution. The increased percentage of TUNEL positive cells is supported by the
apoptotic cascade biomarker data presented earlier in this Dissertation. The cells
in these two treatment groups experienced decreased amounts of mitochondrial
cytochrome c, corresponding increased amounts of cytochrome c in the cytosol,
no increase in Bcl-2 and increased percentage of caspase-3 positive cells all
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culminating in an increased percentage of apoptotic cells as demonstrated in this
figure. These data are derived from the Hsp70 ELISA and TUNEL staining.
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Fig 43. Percentage of TUNEL positive cells vs. Hsp70 content in the cells
during disinfection in the 37°C and 37°C+GLN treatment groups. These data
demonstrate the relationship between incubation at 37°C during disinfection,
increased levels of Hsp70 and the percentage of TUNEL positive cells detected
in the tissue. The increased percentage of TUNEL positive cells in the 37°C
treatment group is supported by the apoptotic cascade biomarker data presented
earlier in this Dissertation. The cells in the 37°C treatment group experienced
decreased amounts of mitochondrial cytochrome c, corresponding increased
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amounts of cytochrome c in the cytosol, a small increase in Bcl-2 and increased
percentage of caspase-3 positive cells all culminating in an increased percentage
of apoptotic cells as demonstrated in this figure. However, the 37°C plus Gin
treatment group demonstrated nearly an opposite outcome in pro-apoptotic and
anti-apoptotic biomarkers thereby resulting in tissue that did not have elevated
levels of apoptotic cells as demonstrated by TUNEL staining.
4.15 VISUALIZATION OF APOPTOTIC CELLS POST-CRYOPRESERVATION

To determine whether incubation at 37°C or 37°C plus Gin during the
antibiotic treatment phase would result in maintenance of baseline levels of
TUNEL positive cells in aortic conduit tissue that had been subsequently
cryopreserved, thawed and incubated at 37°C under 5% C02 for 72 hours,
TUNEL staining and histomorphometry were used to detect and quantitate
apoptotic cells. The tissue was incubated for 24 hours in antibiotics at the
experimental temperatures, 4°C and 37°C, with or without Gin, cryopreserved,
thawed and diluted of cryoprotectant and incubated in tissue culture media
optimized for the viability of vascular smooth muscle cells over 72 hours at 5%
C02 as described in the Materials and Methods chapter. The data were obtained
by dividing the total number of TUNEL positive cells in the tissue section by the
total number of cells present in the tissue sections on the companion slides and
obtaining the percentage of positive cells. The TUNEL data were normally
distributed
Figure 44 demonstrates that the 4°C and 4°C plus Gin treatment groups
experienced a significant increase in TUNEL positive cells over baseline, p<0.05,
specifically between 0 and 48 hours, p<0.05. The number of TUNEL positive
cells in the 37°C treatment group was significantly lower than the 4°C and 4°C
plus Gin treatment groups, p< 0.05. However, the 37°C treatment experienced a
statistically significant increase in TUNEL positive cells between 6 and 72 hours
of incubation, p < 0.05. The 37°C plus Gin group did not experience a statistically
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significant increase in the percentage of TUNEL positive cells over baseline, p>
0.05. Figure 45 demonstrates that a lack of Hsp70 production correlates with
increased rate of TUNEL positive cells in both 4°C treatment groups. Figure 46
demonstrates that increased amounts of Hsp70 correlate with no increase in
TUNEL positive cells in the 37°C with Gin treatment group. Representative
micrographs of TUNEL stained tissue sections are provided in Figures 47-51.
These data demonstrate that cells incubated at 37°C with Gin do not
experience an increase in TUNEL positive cells, relative to the other three
treatment modalities. The data also demonstrate the advantage conferred to the
cells in the 37°C plus Gin treatment over those in the 37°C without Gin treatment
group.
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FIGURE 44. Quantitation of TUNEL positive cells in aortic conduit tissue
after cryopreservation. Treatment of human aortic conduit previously incubated
at 37°C plus Gin during antibiotic disinfection, cryopreserved, thawed and
incubated under cell culture conditions results in no significant increase in
TUNEL positive cells over time, post cryopreservation relative to treatment at 4°C
prior to cryopreservation. Tissues were incubated under their respective
conditions, formalin fixed; paraffin embedded, sectioned and investigated using
the TUNEL assay. Positive control slides were 42% positive.

116

2000

35
•••4C TUNEL
t=34C + GLN TUNEL
-^4C HSP70
^-4C + GLN HSP70

1200 5

1000 g

6

24

TIME (HOURS)

FIGURE 45. Percentage of TUNEL positive cells vs. Hsp70 content in the
cells post-cryopreservation in the 4°C and 4°C+GLN treatment groups.
These data demonstrate the relationship between incubation at 4°C during
disinfection, maintenance of baseline levels of Hsp70 and increasing percentage
of TUNEL positive cells detected in the tissue post-cryopreservation. The
increase in percentage of TUNEL positive cells was similar with or without the
addition of Gin to the 4°C disinfection solution. The increased percentage of
TUNEL positive cells is supported by the apoptotic cascade biomarker data
presented earlier in this Dissertation. The cells in these two treatment groups
experienced decreased amounts of mitochondrial cytochrome c, corresponding
increased amounts of cytochrome c in the cytosol, no increase in Bcl-2 and
increased percentage of caspase-3 positive cells all culminating in an increased
percentage of apoptotic cells as demonstrated in this figure. These data are
derived from the Hsp70 ELISA and TUNEL staining results.

117

2000

35
I37C TUNEL
30

I37C + GLN TUNEL
•37C HSP70
•37C + GLN HSP70

! 25

oUi
2 20
ui

1000 S

OUi
1
15
oocUi
ui

10

mill
2

6

24

TIME (HOURS)

FIGURE 46. Percentage of TUNEL positive cells vs. Hsp70 content in the
cells post-cryopreservation in the 37°C and 37°C+GLN treatment groups.
These data demonstrate the relationship between incubation at 37°C during
disinfection, increased levels of Hsp70 and the percentage of TUNEL positive
cells detected in the tissue post-cryopreservation. The increased percentage of
TUNEL positive cells in the 37°C treatment group is supported by the apoptotic
cascade biomarker data presented earlier in this Dissertation. The cells in the
37°C treatment group experienced decreased amounts of mitochondrial
cytochrome c, corresponding increased amounts of cytochrome c in the cytosol,
a small increase in Bcl-2 and increased percentage of caspase-3 positive cells all
culminating in an increased percentage of apoptotic cells as demonstrated in this
figure. However, the 37°C plus Gin treatment group demonstrated nearly an
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opposite outcome in pro-apoptotic and anti-apoptotic biomarkers thereby
resulting in tissue that did not have elevated levels of apoptotic cells as
demonstrated by TUNEL staining.
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FIGURE 47. TUNEL Positive Control. Micrograph demonstrating pink nuclear
staining and blue staining of TUNEL positive nuclei, 200X. Examples of TUNEL
positive cells are indicated by the arrows. Forty-two percent of the cells are
TUNEL positive.
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FIGURE 48. TUNEL negative control. Micrograph demonstrating pink nuclear
staining and absent blue staining for TUNEL positive cells, 200X. The negative
control was generated by adding nuclease to the tissue to nick the DNA but
omitting the TdT from the reaction mixture to prevent labeling of the nicked DNA
on the 3' hydroxyl groups.

FIGURE 49. Baseline TUNEL staining. This micrograph is of a tissue section
from the 37°C + Gin experimental group at 0 time post thaw to demonstrate a
sample where thresholding revealed that approximately 5% of the cells were
TUNEL positive, 100X. The nuclei stain pink and TUNEL positive cells stain blue.
The arrows are pointing to the areas, which were TUNEL positive.
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FIGURE 50. TUNEL micrograph, 25% positivity. This micrograph is of a tissue
section from the 4°C plus Gin experimental group at 6-hours post-thaw to
demonstrate a sample where thresholding revealed that approximately 25% of
the cells were TUNEL, 100X. The nuclei stain pink and TUNEL positive cells
stain blue. The arrows are pointing to the areas, which were TUNEL positive.
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FIGURE 51. TUNEL micrograph, 45% positivity. This micrograph is of a tissue
section from the 4°C experimental group at 48-hours post-thaw to demonstrate a
sample where thresholding revealed that approximately 45% of the cells were
caspase-3 positive, 100X. The nuclei stain pink and TUNEL positive cells stain
blue. The arrows are pointing to the areas, which were TUNEL positive.
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CHAPTER 5
DISCUSSION

It is well established in the peer-reviewed literature that the constitutive
cells in allograft heart valves are apoptotic upon implantation (8, 68, 69, 70, 71).
As a result, the graft calcifies, decellularizes in situ and ultimately will fail due to
stenosis (lumen narrowing) caused by the calcification (8). Therefore, developing
a methodology to avert the apoptotic cascade would be clinically relevant and
benefit the thousands of adults and children who receive lifesaving allograft heart
valves annually. Hence, the specific aims of this research were three fold: 1) to
ascertain if the constitutive cell population in allograft heart valves would perceive
being transferred from a 1-10°C transport solution to a 37°C disinfection solution
as heat shock; augmenting the amount of Hsp70 in the cells as well specific antiapoptotic proteins, 2) to ascertain if addition of Gin during disinfection would
augment the amount of Hsp70 in the cells as well as specific anti-apoptotic
proteins and 3) to ascertain if the initial heat shock during disinfection would pre
condition the cells such that, in response to subsequent hypothermic storage and
heat shock the amount of Hsp70 would be augmented in a shorter period of time
and increase specific anti-apoptotic proteins. To investigate these hypotheses,
generously donated human aortic conduit tissue was subjected to one of four
treatment regimes during disinfection: 1) 4°C, 2) 4°C plus Gin, 3) 37°C and 4)
37°C plus Gin. To determine the ability of the four treatment regimes to augment
the Hsp70 response and where the anti-apoptotic effect could be detected, the
amount of Hsp70, cytoplasmic and mitochondrial cytochrome c and Bcl-2 were
quantitated using ELISA and the number of caspase-3 and TUNEL positive cells
were quantitated histomorphometrically. Tissue from each of the four groups was
then cryopreserved, stored in nitrogen vapor, thawed and diluted of
cryoprotectant, placed in smooth muscle cell nutrient media and incubated at
37°C under 5% C02 for 72 hours. During this second heat shock, the tissues
were assessed for the same target proteins as before. This second incubation
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was performed to simulate the in situ situation post-transplantation (specific aim
three).
The current research produced three significant outcomes. They are: that
the constitutive cellular population in allograft heart valves perceived going from
1-10°C to 37°C as heat shock; they can be pre-conditioned to respond to
subsequent heat shock; and the magnitude and rate of Hsp70 augmentation was
potentiated by Gin. These observations led to an important discovery on the
mechanism of apoptosis related to heat shock of allograft cells during
processing. It is that the amount, rate and the timing of the heat shock response
are critical to prevent the apoptotic cascade from proceeding through to
completion. This evidence is supported in part by maintenance of baseline
amounts of cytochrome c in the mitochondria and cytosol, significant
augmentation in Bcl-2 levels and no increase in caspase-3 and TUNEL positive
cells in the 37°C plus Gin group. Therefore, a significant augmentation in Hsp70
levels in a time dependent manner was able to halt the progression of the
apoptotic cascade in allograft constitutive heart valve cells.
The Hsp70 data demonstrated several phenomena. As anticipated the
constitutive heart valve cells were unresponsive to the effects of Gin when the
tissue was disinfected at 4°C. This result is attributed the cell's metabolic
processes being significantly hindered at 4°C. However, the 4°C and 4°C plus
Gin provided data on the upper limit on how long tissue could be stored at 4°C
and still perceive being incubated at 37°C as heat shock. After cryopreservation
these tissues were placed at 37°C for 72-hours; however, they demonstrated no
evidence of augmented Hsp70 or the presence of any other anti-apoptotic
biomarkers. It is thought this occurred because a significant portion the
constitutive cells in both groups were already committed to the apoptotic cascade
as evidenced by the data in Figures 8, 9, 11,14,17, 21, 24, 27, 30, 41 and 44.
The cells could not respond to heat shock as that would have required ATP
metabolism and commitment to transcription and translation by the cells;
however, no metabolic assay was executed at the time to confirm this
hypothesis. Therefore, based upon these observations, the maximum amount of
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time that the constitutive cells in allograft heart valves can be at stored at 4°, and
still perceive being returned to 37°C as shock, is approximately 23 hours.
The Hsp70 data coupled with the performance of the other apoptotic
biomarkers clearly demonstrate that augmentation of Hsp70 is not sufficient to
prevent progression through the apoptotic cascade. The 37°C and 37°C with Gin
data supports this conclusion. The levels of expression of the anti-apoptotic
biomarker Bcl-2 in these groups is a good example of this conclusion. Figure 23,
that overlays the Hsp70 augmentation data on the Bcl-2 augmentation data
demonstrates that even though the Hsp70 levels in the 37°C group increased
approximately six-fold over the 24-hour disinfection period, the amount of Bcl-2
present barely doubled. Whereas, the 37°C plus Gin group had significant
increases in Hsp70, sixteen-fold, between one and six hours. This magnitude
and time course correlates with a six-fold increase in Bcl-2 that began after three
hours of incubation at 37°C. Between two and four hours of incubation Hsp70
increases dramatically and is accompanied by a five-fold increase in the amount
of Bcl-2 present. During the second phase of the research, 72-hour incubation in
vitro, the 37°C group maintained a steady state of Hsp70. This could have been
the result of extended mRNA half-life; extended protein half life and/or a modest
amount of hsp70 transcription and translation at the same rate it was being
degraded. This lack of augmentation in Hsp70 correlated to little or no increase in
Bcl-2. Conversely, Hsp70 increased markedly in the 37°C plus Gin group as did
the Bcl-2 levels. These observations, correlate with the temporal appearance of
pro-apoptotic biomarkers. All three specific aims were achieved with respect to
increased Hsp70 in response to 37°C incubation, increase in a pro-apoptotic
protein and that the constitutive cells can be pre-conditioned to produce Hsp70
more efficiently after a second hypothermic-euthermic cycle.
The cytochrome c results also provide an excellent example of the
importance of having augmented amounts of Hsp70, but more importantly having
it present early in the disinfection phase and at significant quantities. Paired
Figures 9/15 and 10/16 provide a stark contrast to one another and support this
assertion. Figures 9/15 (4°C and 4°C plus Gin) demonstrate that in the absence
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of augmented Hsp70, cytochrome c exits the mitochondria and enters the cytosol
and the mitochondrial fraction is never restored. However, in Figures 10/16 the
presence of increased amounts of Hsp70 modulates the amount of cytochrome c
that exits the mitochondria and enters the cytosol. This figure also demonstrates
the significance of having Hsp70 present early and in significant amounts. This
observation provides, perhaps, a glimpse inside the cells. The data are
consistent with the hypothesis that there are significant pro-apoptotic conditions
present inside the cell such as large amounts of denatured proteins as a result of
the hypothermic transport. In addition to the physiologic insult of hypothermic
transport, there is the period of time that the donor valves are still in situ awaiting
procurement (10.0 - 13.8 hours for the study tissues) that likely contributes to the
milieu of denatured proteins that can activate the intrinsic apoptotic cascade.
During this period of time the donor is usually placed into a morgue where the
body is held at 1-10°C but the body temperature does not equilibrate prior to
procurement. There, are of course, other potential activators of the apoptotic
cascade present such as hypoxia, acidosis and increased calcium content, to
name a few.
The caspase-3 and TUNEL immunohistochemistry results obtained further
corroborate the pro-apoptotic conditions present during routine disinfection at
4°C and the effect of heat shock in the presence of Gin during disinfection. It is
important to recall that all of the groups contained apoptotic cells at the initiation
of the study and as such it was expected to observe them throughout the course
of the study in all treatment groups at the established (time zero) baseline levels.
Paired Figures 28/42 and 29/43 (caspase-3 immunohistochemistry and TUNEL
staining, respectively) illustrate that the lack of augmented amounts of Hsp70
correlate to an increasingly large population of the constitutive cells in the
allograft heart valves being committed to the apoptotic cascade. Specifically,
after 24-hours of disinfection at 4°C both groups contain 27-30% caspase-3
positive cells and 17-23% TUNEL positive cells (Figures 28 and 42). This
correlates well to the previous data that demonstrate the pro-apoptotic protein
cytochrome c entering the cytosol in large amounts and no augmentation in the
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anti-apoptotic protein Bcl-2. Conversely, Figures 29 and 43 demonstrate that
augmentation in Hsp70 levels modulates the apoptotic cascade. The constitutive
cell population in the 37°C group was approximately 15% caspase-3 and TUNEL
positive. This is reduced relative to the 4°C treatment groups; however, the 37°C
plus Gin group experienced no increase in caspase-3 and TUNEL positive cells.
Again, the importance of Gin is clear. Without Gin supplementation there is a
threefold increase in the percentage of cells committed to the apoptotic cascade
that will be unable to contribute to the renewal of the extracellular matrix once the
heart valve is transplanted and in situ.
The data obtained during this study are easily contextualized with the
results reported by others and it becomes possible to say that Hsp70 was
induced in the 37°C and 37°C plus Gin experimental groups even in the absence
of Hsp70 mRNA quantitation (113). This is reasonable due to the work of Liu and
Cullen (33,18). Liu demonstrated a direct correlation between the amount of time
that human fibroblasts (IMR-90) were at held at hypothermic conditions (4°C) and
the amount of Hsp70 present after heat shock at 37°C. These data were derived
through a compilation of Western blot/densitometry, pulse labeling the cells with
Trans 35 S-label, gel mobility shift assay for HSF-1 binding to the HSE and
quantitation of the hsp70 mRNA. They demonstrated a 7.7 fold increase in
mRNA the corresponded to a similar increase in Hsp70 after heat shock. Cullen
demonstrated that animals held at 2-8°C and returned to room temperature
experienced an eight fold increase in the amount of hsp70 mRNA. This
correlates well with the six to seven-fold increase in Hsp70 measured in the 37°C
group. Additionally, this group demonstrated the longer the animals were
exposed to hypothermic conditions the more hsp70 mRNA was detected (18).
The additional amounts of Hsp70 detected during the current research could be
due to the extensive amount of hypothermic insult (18-20 hours) and the
potentation of Hsp70 transcription by Gin. Therefore, put into context the data
reported herein indicate that the constitutive cells in allograft heart valves cells
can be induced to produce significant amounts of Hsp70, especially in the
presence of Gin. Further, the data support that induction of Hsp70 correlates
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significantly with an increase in the anti-apoptotic protein Bcl-2 and prevents the
appearance of pro-apoptotic proteins such as cytochrome c and caspase-3.
To continue to contextualize the results presented herein, Mosser et al
demonstrated that hsp70 transfected cell lines that over expressed Hsp70
protected the cells from becoming apoptotic when subjected to physiological
stress by blocking the release of cytochrome c from the mitochondria (59). This
correlates with the results presented herein that induction of Hsp70 (37°C
treatment group) modulates the amount of cytochrome c released after
physiological stress. However, Mosser's data most closely correlated with the
37°C plus Gin group where the amount of Hsp70 present was 16-fold greater
than baseline and prevented cytochrome c from exiting the mitochondria.
The effects of Gin previously reported in the literature also substantiate
the 37°C plus Gin results reported herein. Both Wischmeyer and Ropeleski have
demonstrated that Gin potentiates the transcription of Hsp70 during heat shock
through an indirect mechanism (7, 72). They postulate that Gin increases binding
of HSF-1 to the HSE, affects the chromatin organization of the 5' flanking regions
of the Hsp70 gene and that Gin enhances phosphorylation of nuclear HSF-1.
This step is the final part of the HSF-1 transactivation pathway leading to
transcription of Hsp70. The effect on the 5' untranslated region is corroborated by
Rubtsova team that has demonstrated Hsp70 has an internal ribosomal entry site
to potentiate translation (17). Ropelenski also determined that there are no Gin
dependent differences in HSF-1 phosphorylation, trimerization, nuclear
localization, or HSF-1 promoter activity (121). These results support the
differences observed during this research between the 37°C and 37°C plus Gin
experimental groups. The 37°C resulted in Hsp70 induction though, the amount
and timing was insufficient to halt the progression of the apoptotic cascade.
However, in the presence of Gin the amount and time course of Hsp70
production was significantly augmented and this benefit was realized by the
constitutive cells in the tissue as they expressed Bcl-2, had no loss of
mitochondrial cytochrome c and where free of increased amounts of caspase-3
and TUNEL positive cells.
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Based upon these results, it is possible to propose a mechanism of action
for how the constitutive cells in allograft heart valves are rescued by disinfecting
them at 37°C in the presence of Gin. This proposed mechanism also
demonstrates that the specific aims of this research were successfully achieved.
It should be noted, that this mechanism of action involves some level of
speculation and therefore it should be viewed as a hypothesis. The mechanism
can be based upon Figures 1 and 5 and they are provided again below as
Figures 52 and 53 (pages 128 and 129 respectively) for ease of reference.
The physiological insults to the cells begin after death and are
accentuated when the heart is placed in 1-10°C transport solution. During
transport the intracellular proteins are denaturing. When tissues in the 37°C plus
Gin, as demonstrated in Figure 52, are placed in disinfection media, and
supplemented to contain 10 mM Gin, they experience an increase in hsp70
transcription and translation. This increase is likely due to Gin acting as a transactivator of the process by perhaps increasing the efficiency of HSF-1 binding the
HSE. It is also highly probably that the integrity of the lipid membrane is not intact
and calcium from the RPMI1640 disinfection media is diffusing into the cells. This
diffusion of calcium can be pro-apoptotic. The swift increase in Hsp70 facilitates
efficient refolding of the significant number of denatured proteins to decrease the
pro-apoptotic signals. Additionally, the integrity of cell membrane has likely been
restored. The remaining Hsp70 is acting at various points in the apoptotic
cascade to negatively regulate the progression, Figure 53 on page 129. The
most downstream point of interference, supported by the data presented herein,
is preventing activation of procaspase-3 by caspase-9 perhaps by steric
hindrance of the cleavage site by Hsp70. The next point of regulation would be
inhibition of Apaf-1 activation by cytochrome c. Again, this could be
accomplished through steric hindrance of the cytochrome c binding site on
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FIGURE 52. Hsp70 Inductive Signals, Hsp70 Gene Activation and Hsp70
Synthesis. A myriad of extracellular stimuli can result in activation of the heat
shock response. Inducible Hsp70 transcription factors (HSFs) are bound to
Hsp70 in the cytosol and maintained in an inactive state. However, upon
application of an external stressor the HSFs separate from Hsp70 are
phosphorylated (P) by protein kinases and form trimer complexes in the cytosol.
The complexes proceed to the nucleus, enter and bind to heat shock elements
(HSE) in the promoter region of the Hsp70 gene. Transcription of Hsp70 mRNA
commences and exits the nucleus and enters the cytosol, where new Hsp70 is
synthesized (21).
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FIGURE 53. Multiple Negative Control Points in the Apoptotic Cascade that
Hsp70 May Modulate. The potential points where Hsp70 may negatively
regulate the apoptotic cascade are as follows: 1) Inhibition of stress-activated
protein kinase pathway (SAPK/JNK) phosphorylation and activation of
transcription factors and caspases, 2) Inhibition of pro-caspase-3 transformation
into caspase-3 and committing the cell to apoptosis, 3) Prevention of cytochrome
c release from the mitochondria by increasing the amount of Bcl-2, 4)
Competition for Apaf-1 binding sites on the apoptosome during recruitment of
pro-caspase-9 to the apoptosome, 5) Inhibition downstream of caspase-3
activation potentially. (53)
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Apaf-1 or physical competition for the site. A point in the cascade where
cytochrome c is the target protein would be Hsp70 potentiating the transcription
and translation of Bcl-2. This would prevent cytochrome c from exiting
mitochondrial intermembrane space, binding to Apaf-1, activating caspase-9 and
subsequently caspase-3 which commits the cells to the apoptotic cascade. The
other points of regulation detailed in the drawing are not supported by the
research presented herein and thus will not be pondered.
From this proposed mechanism it is possible to understand that not
producing enough Hsp70 in a prescribed timeframe would result in a portion of
the cells progressing through the apoptotic cascade. This is hypothesized to be
the explanation for why the 37°C group was only partially successful in rescuing
the cells from becoming apoptotic.
There are several experiments that could have been performed or
performed differently that would strengthen the conclusions. It would have been
beneficial to have an experimental group that was classically heat shocked. This
was not possible with human tissue because of the logistics of the donation
process. It can take up to 24-hours for tissue to be procured because of the time
involved to gain consent, assemble the recovery team, travel time and gaining
access to an operating room. However, a classically heat shocked group could
have been accomplished through use of an animal model but the potential issue
raised by using animal tissues is the applicability of the data to human tissues. If
an animal model had been pursued, the heart could have been procured at
asystole, a control tissue sample obtained at the time of death and the remaining
tissue classically heat shocked at 44°C for approximately 50 minutes with no
previous hypothermic storage. The information derived from this control group
would have been the amount of Hsp70 and Bcl-2 at baseline and the amounts
produced through classical heat shocking versus hypothermic-euthermic induced
heat shock. This would have allowed the Hsp70 and Bcl-2 results to be framed
against the results from the classically heat shocked group. Another control
group that only could have been obtained using an animal model would be to
pharmacologically induce the intrinsic apoptotic cascade and frame the 4°C and
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4°C plus Gin caspase-3 and TUNEL results in the context of this group. A
pharmacologically induced group would have provided a different view of heat
shock in the absence and presence of Gin to more fully characterize the ability of
Gin to induce sufficient quantities of Hsp70 to avert progression of the apoptotic
cascade in that group as well.
Another approach to understand the importance of Hsp70 in halting the
progression of the apoptotic cascade would be to utilize RNAi to block translation
of the Hsp70 mRNA or Hsp70 knockout mice. Neither of these models was
available at the time this research was conducted. The data that would have
been gleaned from these approaches would be whether or not other heat shock
proteins are capable of performing the same job as Hsp70 in modulating the
apoptotic cascade. Current literature points to the importance of Hsp70 plays in
regulating progression through apoptosis using both of these model systems (72,
73). The RNAi researchers were using this molecular technique to inhibit Hsp70
to treat gastric cancer, as it is over expressed in this disease process. They
demonstrated RNAi to hsp70 mRNA successfully down-regulated the presence
of Hsp70 in the cells and consequently the cancerous cells preceded through the
apoptotic cascade - a desirable outcome in this instance (72). Lee et a/I
investigated the effects of Hsp70.1 gene knockout on the mitochondrial apoptotic
pathway after focal cerebral ischemia in the mouse model (73). Much like the
research conducted in the course of this Dissertation they investigated
cytochrome c release from the mitochondria, caspase-3 activation and the
presence of TUNEL positive cells. Their functional results indicate the knockout
mice had significantly larger infarct areas relative to wild type mice. After eight
hours of ischemia they observed markedly increased amounts of cytochrome c in
the cytoplasm of the knockout versus the wild type mice who also were
expressing significantly increased amount of Hsp70 (73). The capsase-3 results
also align with the observations in this Dissertation, physiological insult without
subsequent Hsp70 induction results in a significant portion of the cell population
to be caspase-3 positive and as such committed to the completion of the
apoptotic program.
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The data presented herein, coupled with data in the peer reviewed
literature in the field allow the following conclusions to be drawn: 1) the
constitutive cell population in allograft heart valves perceive being transferred
from a 1-10°C transport solution to a 37°C disinfection solution as heat shock;
and augments the amount of Hsp70 in the cells as well specific anti-apoptotic
proteins, 2) Gin supplementation of the disinfection solution augments the
amount of Hsp70 in the cells as well as specific anti-apoptotic proteins and 3) the
initial heat shock during disinfection pre-conditions the cells such that, in
response to subsequent hypothermic storage and heat shock the amount of
Hsp70 is augmented in a shorter period of time and specific anti-apoptotic
proteins are increased. Therefore the proposed change to the disinfection
solution composition and incubation temperature has the strong potential to
improve current allograft heart valve processing, and that of other allograft cells,
organs and tissues, such that durability of the heart valve and resistance to
calcification improve the many physiological and functional benefits of allograft
heart valves for the thousands of adults and children annually that need these life
saving allografts.
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CHAPTER 6
CONCLUSIONS AND FUTURE RESEARCH

This research has conclusively demonstrated the benefits of incubating
aortic conduit tissue at 37°C with Gin supplementation during the disinfection
process prior to cryopreservation. The experimental treatment modality heat
shocked the tissue as a result of returning the tissue to physiological temperature
after hypothermic transport. Hsp70 formation however cannot be fully attributed
to heat shock, Gin also likely contributed to the increased amount of Hsp70
detected. The data also demonstrated the constitutive cells in the heart valve
tissue can respond to additional hypothermic - euthermic temperature cycling in
a more efficient manner as measured by Hsp70 formation over time and
resistance to apoptosis. The amounts of Hsp70 produced are able to stimulate
production of other anti-apoptotic proteins such as Bcl-2. The production of Bcl-2
ensures little to no leakage of cytochrome c into the cytosol that can stimulate the
intrinsic apoptotic cascade through activation of the apoptosome.
This research has conclusively demonstrated that only elevating the
temperature of the tissue to 37°C or incubating the tissue at 4°C with Gin is not
sufficient to induce adequate production of protective levels of Hsp70 to ensure a
cell population with minimal apoptosis. Rather, both approaches, 37°C and Gin,
should be employed.
The results of this Dissertation research support the findings of previous
researchers and expand the scientific knowledge base by providing a practical
application for this naturally occurring phenomenon. The biological response of
the cells to hypothermia and subsequent return to physiological condition as heat
shock is elegant. It is not surprising that there is an evolutionarily conserved
mechanism to support the cell during extremes in temperature. The ability of cells
to exploit the heat shock response from a cold perspective is an excellent
example of key survival mechanism being evolutionarily conserved. Rather than
the heat shock response being a utilitarian response to increased temperature,
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the molecular biology is in place for the cells to perceive their return to
physiological conditions as heat shock after hypothermic exposures. The benefits
of hypothermia for surgeries augment these findings. One could easily imagine
Hsp70 aiding the body in the recovery process postoperatively and protecting the
cells from the trauma of surgery. The balance seen in the 37°C plus Gin
experimental group's cells ability to produce high levels of Hsp70 and Bcl-2
coupled with increased resistance to cytochrome c leakage from the cells,
increased resistance to caspase-3 formation and subsequent resistance to
apoptosis speaks to the benefits of exploiting these outcomes to benefit the
patients receiving cryopreserved allografts and thus overcoming their main cause
of failure apoptotic cells. As the apoptotic cells serve as nidi for calcification
which leads to stenosis thus impairing the performance of the heart as it is
pumping against a pressure gradient and may hypertrophy.
The future of this research should involve quantitation of Hsp70 mRNA in
parallel with the Hsp70 ELISA to confirm that Hsp70 was actually being
transcribed during the incubation. Quantification of the intracellular calcium
concentration during the course of the incubation would determine if a rise in
intracellular calcium is contributing to initiating the apoptotic cascade. Executing
the animal models described earlier would further solidify the validity of the
observation made during the current research. Additionally treating hearts per
normal protocol, 4°C without Gin and at 37°C with Gin and implanting the
resultant heart valves in a female juvenile sheep model for 20-weeks would allow
one to ascertain if there is actual physiological benefit to the 37°C plus Gin
treatment.
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